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Abstract
Background: Among patients with multiple chronic conditions, care coordination and
integration remains one of the major challenges facing the U.S. health care system. A
home-based, patient-centered primary care program has been offered through the
Veterans Health Administration (VHA) since the 1970s for frail veterans who have
difficulty accessing VHA clinics. The VHA Home Based Primary Care (VHA HBPC)
aims to integrate primary care, rehabilitation, disease management, palliative care, and
coordination of care for frail individuals with complex, chronic diseases within their
homes. Early research suggested that VHA HBPC was associated with positive
outcomes (e.g., reduced resource use and patient satisfaction). However, evidence
regarding the effect of the VHA HBPC program on health services use (especially
hospital and nursing home use), expenditures, and other patient outcomes remains
limited. The present study is designed to fill this gap as the rise in the number of
veterans with complex health care needs will likely increase in the coming decades.
Objectives: The current study aimed to examine the impact of VHA HBPC on health
services use, expenditures, and mortality among a cohort of new VHA HBPC enrollees
identified in the national VHA data system. The specific aims of this study were: 1) to
examine the effect of VHA HBPC on major health service use (hospital, nursing home,
and outpatient care) paid for by the Veterans Administration; 2) to examine the effect of
VHA HBPC on total health services expenditures; and 3) to examine whether VHA
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HBPC enrollees experienced similar mortality and survival as compared to a matched
concurrent cohort.
Methods: This study used a retrospective cohort design. A new VHA HBPC enrollee
cohort (the treatment group) and a propensity matched comparison cohort (the
comparison group) were identified from VHA claims in fiscal years (FY) 2009 and 2010
and were followed through FY 2012. Data on health service use, expenditures, and
mortality/survival data were obtained via the VHA administrative datasets (i.e., Decision
Support System, Purchased Care, and Vital Status Files). Propensity scores of being
enrolled in the VHA HBPC were generated by a logistic regression model controlling for
potential confounders. After 41,244 matched pairs were determined adequate through
several diagnostic methods, means tests, relative risk analyses, and generalized linear
models were used to estimate the effect of VHA HBPC on outcomes. Additionally, a
Cox proportional hazards regression model was used to estimate the effect of VHA
HBPC on survival. Subgroup analyses were conducted stratifying by age (85 and older),
comorbidities (2 or more), and the receipt of palliative care. Based on the results of the
original analyses, a series of sensitivity analyses were conducted that modified the
described sample selection criteria and matching algorithm.
Results: Analyses of the original cohort revealed that VHA HBPC patients had
significantly higher risks of being admitted into a hospital (RR 1.53, 95% CI 1.51-1.56)
or nursing home (RR 1.65, CI 1.50 - 1.81). The average total expenditures during the
study period were significantly higher for the VHA HBPC group as compared to the
control group ($85,808 vs. $44,833, respectively; p < .001). In terms of mortality and
survival, VHA HBPC enrollees had higher mortality (RR 1.45, CI 1.43 – 1.47), and
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shorter survival (HR 1.89, CI 1.86 – 1.93) as compared to those in the comparison
group. Subgroup analyses found that these relationships generally remained when
stratified by age 85 or older or having two or more comorbidities. However, for those
who received palliative care, VHA HBPC participants had significantly lower risk of VHA
hospitalization overall (RR 0.84, CI 0.81 – 0.87) and immediately prior to death. Finally,
exploratory post-hoc analysis suggested that VHA HBPC recipients were at higher risk
of VHA hospitalization at 30 (RR 1.11, CI 1.06 – 1.16), 60 (RR 1.16, CI 1.11 – 1.20),
and 90 days (RR 1.16, 1.12 – 1.21) prior to death relative to the comparison group.
After selecting only those that had a baseline hospitalization and refining the matching
algorithm to account for time to death and additional comorbidities, VHA HBPC
participants who had been enrolled in the program for at least six months had lower
risks for hospital (RR 0.89, CI 0.88 – 0.90) and nursing home admissions (RR 0.74, CI
0.67 – 0.81). However, total expenditures remained significantly higher among those in
VHA HBPC relative to the comparison group ($89,761 vs. $85,371, respectively; p
< .001).
Discussion: This study found that without accounting for important covariates such as
initial hospitalization, time to death, and a range of comorbidities, VHA HBPC was
associated with higher health service use, higher expenditures, higher mortality, and
shorter survival as compared to a similar group of patients not receiving VHA HBPC.
After accounting for these factors, VHA HBPC was associated with a lower risk of
nursing home use, and after six months, VHA HBPC was associated with lower risk of
both nursing home and hospital use. These findings suggest that while VHA HBPC
may improve quality of life and patient satisfaction through patient-centered integrated
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primary care, it may not generate cost savings for the healthcare system. Future
research is needed to understand variation in program implementation and how this
affects the impact of VHA HBPC on service use and cost.

viii

Chapter 1: Background

Introduction
The importance of primary care is underscored by the Agency for Healthcare
Research and Quality’s notion of primary care being “foundational” to achieving a better
healthcare system (Agency for Healthcare Research and Quality, 2013b). Primary care
physicians are the most common type of physician utilized for a single condition or for
multiple conditions among patients with all degrees of comorbidity (Centers for Disease
Control and Prevention, 2010; Starfiled et al., 2003). Even when patients have a high
degree of comorbidity, patients are still more likely to see their primary care physician
compared to a specialist (Centers for Disease Control and Prevention, 2010; Starfiled et
al., 2003).
Patients with comorbidities are prevalent among primary care practices. Among
a sample of 226 primary care practices across 43 states, it was determined that 45.2%
of patients had more than one comorbidity and that comorbidity increases with age
(Ornstein, Nietert, Jenkins, & Litvin, 2013). Focusing on the nature of primary care
practice and the prevalence of comorbidity, Starfield et al. (2003) posited that primary
care should retain its stronghold as the basis for patient care but should also consider
evolving to adequately address patient needs. One of these evolutions in healthcare
has been the rise of the medical home.
Though not a new term, the concept of the medical home has gained in
popularity, as part of a growing effort to provide complex patients with more
1

comprehensive care. The patient-centered medical home is characterized as care that
is continuous, comprehensive, accessible, and coordinated across providers
(Rittenhouse & Shortell, 2009). Additionally, the medical home is one that is teambased according to the patients’ needs and can include an array of providers (e.g.,
specialists, nurses, social workers, pharmacists, therapists). Medical homes, in
particular, have been associated with lower total costs and outpatient costs among the
most costly and complex patients (Flottemesch et al., 2012) and are conceptualized
based on the components of evidence-based medicine and an ongoing partnership
between patients and physicians (American College of Physicians, 2005).
To continue efforts to improve healthcare in general, and in primary care
specifically, the American College of Physicians promotes the delivery of care through
the medical home based on the Chronic Care Model recognizing the complexity and
chronicity of patients and their conditions and posit that this model of care can be
applicable to those with or without chronic conditions (American College of Physicians,
2005). This model of care delivery emphasizes the relationship between the patient and
the physician and care self-management guided by decision support tools that includes
a range of options supporting the patient’s health goals (American College of Physicians,
2005).
Chronic disease management is important to controlling healthcare costs,
especially considering that those with multiple chronic conditions cost up to seven times
as much as those with only one condition (Agency for Healthcare Research and Quality,
2006) and a substantial portion of the rise in costs among Medicare beneficiaries over
the last two decades has been attributed to the management and treatment of chronic
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conditions such as diabetes and hypertension (Thorpe, Ogden, & Galactionova, 2010).
Chronic disease management and treatment was associated with 75% of the $2 trillion
spent on healthcare in the U.S. (Centers for Disease Control and Prevention, 2009,
2013). In 2010, Medicare spent over $300 billion on beneficiaries, and among those
with six or more chronic conditions, the cost was three times as much as the average
Medicare beneficiary (Centers for Medicare & Medicaid Services, 2012). Furthermore,
the Veterans Administration’s (VA) expenditures for chronic diseases were $14.3 billion
over ten years ago (Yu et al., 2003) and such expenses are likely considerably higher
today.
Not surprisingly then, many models of care aim to both enhance patient quality of
care and safety, as well as reduce unnecessary expenses, hospitalizations, adverse
events, and disease exacerbation by providing enhanced care continuity. This is
important because each time there is a change in care, there is an opportunity for
miscommunication where information about patient preferences and goals can be
jeopardized (Coleman, 2003; Hauser, 2009).
Moreover, those individuals that are among the frailest of patients likely have
difficulty accessing healthcare. Access issues span a range of challenges including
social, societal, and behavioral, but fundamentally, decreased access to primary care is
associated with adverse outcomes, for example, higher mortality (Jerant, Fenton, &
Franks, 2012).
Home-based primary care can be a solution for those who cannot receive care in
a traditional clinical setting and has been characterized as an “emerging model of
primary care” (Landers et al., 2005). Given the importance of chronic disease
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management, those who cannot access healthcare due to being homebound are a
group of highly vulnerable patients. There are an estimated 3.6 million older adults who
are considered homebound (Qiu et al., 2010).
Specifically, the homebound have higher rates of metabolic, cardiovascular,
musculoskeletal conditions, and higher rates of cognitive impairment, dementia, and
depression (Qiu et al., 2010). In a study of chronically ill homebound individuals, it was
found that 49% had dementia, 33% had diabetes mellitus, 26% had depression, 18%
had coronary heart disease, and 13% had cancer (Wajnberg, Ornstein, Zhang, Smith, &
Soriano, 2013). Moreover, the same study found that the most common symptoms
among the homebound were loss of appetite, lack of well-being, tiredness, and pain
(Wajnberg et al., 2013).
In the broader healthcare context, primary care provided in patients’ homes has
the potential to effectively fill a gap in services for homebound individuals (Desai, Smith,
& Boal, 2008). Primary care delivered in patients’ homes is delivered mostly by
geriatricians and family or internal medical doctors in order to improve patient care and
autonomy (Landers, Gunn, & Stange, 2009). However, the effectiveness of this model
to improve patient outcomes is mixed, and overall, there seems to be limited evidence
on home-based primary care provided in the U.S. Others have suggested that in order
to expand home-based primary care as a delivery model, more rigorous research on
home-based primary care is needed (Olsan, Shore, & Coleman, 2009).
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Therefore, the current study examines the VHA’s Home Based Primary Care
(VHA HBPC)1 by determining the effectiveness of the program on service use, cost, and
survival. First, a review of the literature on home-based primary care (in general, not
limited to the VHA HBPC program) in the United States is presented. It should be noted
that the literature focused specifically on primary care delivered in the home is limited.
Therefore, this review includes literature on house calls made by physicians specifically
for primary care and includes literature referring to physician house calls that did not
specify primary care, but identified physician’s specialties as geriatricians, family
physicians, general practitioners, or internal medical doctors delivering routine care in
patient’s homes. Following the review, an overview of VHA HBPC is provided including
a review of the evidence. Then, the present study is described, followed by a
discussion of the implications of the results.

Physician Services Provided In Patients’ Homes
Prevalence of Home-Based Primary Care & Physician House Calls. Overall,
very few (<1%) older adults receive a house call from a physician (Landers et al., 2005;
Meyer & Gibbons, 1997). However, there seems to be a re-emergence of such care.
From 1998 to 2004, the annual number of Medicare beneficiaries who received house
calls increased by 43% (Landers et al., 2005). While this is a relatively large increase,
the overall rate of house call utilization remains low, increasing from 0.78% in 1998 to
0.90% of all out-patient evaluation and management services among fee-for-service
Medicare beneficiaries (Landers et al., 2005). Similarly, Peterson, Landers, &

1

The acronym for the Home Based Primary Care, VHA HBPC, is used only when referring to the program
provided through the Veteran’s Health Administration (VHA). When home-based primary care is spelled
out, it is referencing this type of care in general terms, i.e., not specific to the VHA.
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Bazemore (2012) found that the number of physician house calls more than doubled
from 478,000 in 2000 to 995,294 in 2006 among Medicare beneficiaries, coinciding with
an increase in the number of beneficiaries who received house calls (up from 164,825 in
2000 to 282,526 in 2006). However, the number of physicians making house calls
declined, indicating that a smaller number of physicians were seeing a higher volume of
patients in their homes (Peterson et al., 2012). Of note, visits by nurse practitioners
and physicians assistants to patients in the home increased between 1998 to 2004
(Landers et al., 2005).
Using the 2004 National Long Term Care Survey, Liang & Landers (2008) found
that 4% of the sample, or 168 out of 4,953 respondents, reported receiving a house call
from a physician. This rate of receiving a physician house call is high in comparison to
other evidence. Part of the discrepancy in the rate of physician house calls could be
due to the definition of a physician house call and due to the differences between selfreported and claims data.
Recipients of Home-Based Primary Care & Physician House Calls. Those
who receive house calls are often more frail with more functional limitations compared
to those that do not receive this service (Liang & Landers, 2008). Specifically, those
who utilized a physician in the home compared to those that did not utilize a physician in
the home were more often: older (84 years of age versus 81), non-white (17%
compared to 10%), a recipient of Medicaid (23% versus 16%), living in an urban area
(29% compared to 18%), residing in housing that had support for older adults or adults
with disabilities (24% versus 16%), had 2 deficits in activities of daily living (ADLs;
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compared to 1), had 3 deficits in instrumental ADLs (IADLs; compared to 1), and were
more often hospitalized in the last year (37% compared to 28%; Liang & Landers, 2008).
Similarly, in a review of the literature from 1990 to 2006, home-based primary
care models were described as serving those that: are frail, are in need of assistance
with 3 or more ADLs, have IADL dependencies, and, often serve those with a range of
mobility including those that can leave their homes for short durations to those that are
strictly homebound (Olsan et al., 2009). Additionally, these programs typically serve
those that are white, widowed females, age 65 years and older who often have low,
fixed incomes (Olsan et al., 2009). The chronic conditions of those served by these
programs are typical of older adults in general and include: hypertension, heart disease,
congestive heart failure, chronic obstructive pulmonary disease, stroke, diabetes,
depression, dementia, osteoarthritis, cancer, infections, impaired vision and hearing,
falls, pressure ulcers, and malnutrition (Olsan et al., 2009).
A well-established home-based primary care program, St. Vincent’s Hospital’s
Chelsea-Village Program (Kellogg & Brickner, 2000), has served older, frail residents of
New York City since the 1970’s by providing longitudinal, multidisciplinary care in
patients’ homes. The care team is comprised of physicians, resident physicians, nurses,
and social workers. The average patient is 84 years old and is characterized by
common ailments of old age such as, pulmonary and cardiac issues, orthopedic needs,
neurologic disorders, and generalized weakness and frailty (Kellogg & Brickner, 2000).
The program is now known as the Mount Sinai Chelsea-Village House Call Program or
the Mount Sinai Visiting Doctors Program and provides care to the underserved
homebound population (Mount Sinai Hospital, 2013).
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An analysis of 27-years of data from St. Vincent’s Hospital’s Chelsea-Village
Program described it as serving those that mostly lived alone (57.9%), considered
themselves single (22.3%) or widowed (46.8%), and were referred to the program
through the hospital (44.1%) or through someone in the community (49.2%; Kellogg &
Brickner, 2000). A more recent analysis of the program between 2008 and 2010 found
that 75% of new enrollees were female, 36% were White, 43% had Medicaid, 38% lived
with a caregiver, 91% needed assistance with one or more ADLs, and 99% needed
assistance with one or more IADLs (Wajnberg et al., 2013).
Another housecalls program was established in 1980 as part of a larger
ambulatory practice with three geriatricians and two nurse practitioners in Providence,
Rhode Island (Reuben, Fried, Wachtel, & Tinetti, 1998). Between 1993 and 1995 an
analysis of 71 outpatient medical records were reviewed and described the program as
serving mostly females (81% of patients) aged 85 or older (52% of patients) who were
dependent in bathing and dressing (65% and 42% of patients, respectively) and were
treated for acute illnesses (59% of patients) including upper respiratory tract infections,
pneumonia, and congestive heart failure (Reuben et al., 1998). All patients lived within
15 minutes of the medical center but none were able to leave their homes for routine
care due to ambulatory issues, or in a few cases, psychological barriers (Reuben et al.,
1998). Patients were seen, on average, five times a year for either routine or urgent
care (Reuben et al., 1998).
The Effects of Home-Based Primary Care & Physician House Calls. Several
authors have concluded that this mode of the delivering physician’s services is
consistently associated with patient and caregiver satisfaction (Anetzberger, Stricklin,
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Gauntner, Banozic, & Laurie, 2006; Laditka, Jenkins, Trevisani, & Mathews, 2001;
Muramatsu, Mensah, & Cornwell, 2004; Olsan et al., 2009). In particular, patients and
caregivers reported a positive psychological impact from knowing they had access to inhome medical care, and caregivers reported feeling empowered, informed, and relieved
from the burden of transporting patients to and from medical appointments (Muramatsu
et al., 2004). Patients also noted that physician’s house calls provided access to care
they otherwise would not have received (Laditka et al., 2001).
Intended to fill a gap among the homebound, home-based primary care should
decrease the use of other types of unnecessary or inappropriate care by providing
enhanced access to care and care management. To understand the effect of
enrollment into a house calls program, Wajnberg et al. (2010) used a pre-post design to
determine the effect of a house call program on hospitalizations and skilled nursing
facility utilization among a sample of patients in a capitated insurance program, the
Montefiore Medical Center Care Management Company (Wajnberg et al., 2010). It was
found that there was a significant decrease in the rate of hospitalization after enrollment
(61% prior to and 38% after, p < .001) and a significant decline in the use of skilled
nursing facilities (38% before enrollment and 18% after, p < .001; Wajnberg et al., 2010).
The authors suggested that increased access to healthcare could explain the reason for
the change in hospital and skilled nursing facility utilization.
However, the evidence of the effectiveness of these services is not invariable. A
two-year randomized controlled trial of a collaborative model of primary care included
primary care physicians, registered nurses, and case assistants who conducted patient
and family assessments in the patients’ homes or clinic offices, provided home visits or
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clinic visits, and provided coordination and supportive longitudinal care (Schraeder,
Shelton, & Sager, 2001). Compared to a group not receiving treatment, evaluation of
the program did not find a reduction in the rates of hospital use among participants in
the treatment group after the first year (26.4% of treatment group versus 21.7% of
comparison group) or after the second year (25.0% versus 22.6%; Schraeder et al.,
2001). There was also not a significant difference in length of hospital stay (6.0 days
after year 1 and 5.3 after year 2 among the treatment group compared to 5.0 after year
1 and 6.1 in year 2 among the comparison group), or Medicare payments (Schraeder et
al., 2001). Not surprisingly then, the cost of the program was not offset by a reduction
in hospital use. The authors, however, concluded that the intervention enhanced
patient outcomes since those in the treatment group had a significantly lower risk of
death during the second year (odds ratio = 0.51, 95% confidence interval [CI] = 0.29 0.91; Schraeder et al., 2001).
The Business Case for Home-Based Primary Care & Physician House Calls.
In 1993, it was estimated that physician house calls cost Medicare $63.2 million, or 0.2%
of all Medicare physician expenditures (Meyer & Gibbons, 1997). An analysis of the St.
Vincent’s Hospital’s Chelsea-Village Program estimated that the average cost per
person per year of patient care was $3,936 (Kellogg & Brickner, 2000).
The adoption of home-based primary care models has been relatively slow, likely
due to the fact that direct billing of such services does not generate enough revenue to
meet operating costs (Desai et al., 2008). However, Desai et al. argued that such
programs can generate substantial revenue at the systems level despite the inability of
a program to generate enough revenue to operate independently (Desai et al., 2008).
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For example, in fiscal year 2001 a local Midwestern physician’s house call program
generated $623,987 despite the $119,879 deficit incurred to the health system in which
the program operated (Muramatsu et al., 2004). The author described the benefit of the
program to the health system as being the largest referral source for the system’s home
health agency and hospice programs (Muramatsu et al., 2004). Another program,
operated through Johns Hopkins Hospital System, also produced an overall shortfall of
$84,165 in fiscal year 1992 (Finucane, Fox-Whalen, & Burton, 1994). The authors
noted similarly that the benefit of the program from referrals to the hospital was
justification for the program and resources (Finucane et al., 1994).
More recent evidence suggests that home-based primary care can be costeffective. In a well-designed observational analysis of Medicare’s Independence at
Home program, De Jonge et al. (2014) found that recipients had significantly lower
Medicare costs compared to a matched control group. Moreover, the effect of the
program seemed most promising among the most frail, which tend to be generally the
most costly group of patients.

VHA HBPC
A home-based primary care program that serves a demographically different
population (compared to those served in the programs described above) is offered
through the VHA to eligible patients. VHA HBPC offers primary care, rehabilitation,
disease management, palliative care, and coordination of care to frail individuals with
complex, chronic diseases within their homes (Department of Veterans Affairs, 2007).
Although primary care is a focus of the program, VHA HBPC is described as providing
comprehensive in-home long-term care services (Department of Veterans Affairs, 2007)
11

and is operationally similar to that of the patient-centered medical home model. Early
research suggested that VHA HBPC (then referred to Hospital Based Home Care)
provides a comparatively wide array of services to enrollees (Weaver et al., 1995).
VHA HBPC began being offered through the VHA in 1970 as a demonstration
project and was modeled after the program at the Montefiore Hospital in New York
(Cooper, Granadillo, & Stacey, 2007). The VHA’s program was designed to provide
long-term in-home care for older adults that could be cared for at home but were unable
to receive care at outpatient clinics (Cooper et al., 2007). The program was not
designed to be a substitute for long-term institutional care (Cooper et al., 2007).
VHA HBPC is considered unique in that patient-centered services are provided
through an interdisciplinary team in a longitudinal fashion usually through death rather
than care provided only during disease exacerbation (Department of Veterans Affairs,
2007). This is noteworthy because the average VHA HBPC enrollee has more than
eight chronic conditions, limitations in two or more activities of daily living, spends an
average of 315 days in the program (Beales & Edes, 2009), and is often discharged due
to death. Therefore, the VHA HBPC population is a vulnerable population in which high
medical expenses could easily be incurred.
Like other physician house call programs, VHA HBPC aims to reduce the use of
unnecessary services by providing access to care and chronic disease management.
This is important since recently the Congressional Budget Office suggested that the
future costs of VHA healthcare will be “substantially higher” than the amount
appropriated (Congressional Budget Office, 2010). This is due, in part, to the increased
use of medical care provided through the VHA (Marlis, 2012). For example, the
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average daily number of Veterans receiving non-institutional extended care (which
includes VHA HBPC and other programs such as adult day care, skilled nursing and
rehabilitation, and home health) increased from 95,092 Veterans in 2011 to 113,254
Veterans in 2012 to an estimated 120,118 Veterans in 2013 (Department of Veterans
Affairs, 2013).
A Program Description of VHA HBPC. VHA HBPC provides “all-inclusive”
home care to individuals with complex, chronic diseases whose condition is likely to
worsen over time (Department of Veterans Affairs, 2007). This program was originally
established in 1972 as the Hospital Based Home Care program and has since been
renamed the Home Based Primary Care Program to better reflect the setting in which
care is most often provided (Department of Veterans Affairs, 2007).
Continuous patient-centered care led by a physician-supervised interdisciplinary
team is provided in the homes of Veterans. Specifically, VHA HBPC enrollees are
monitored on an ongoing basis, have routine comprehensive assessments to prevent or
detect the worsening of a condition, and receive timely interventions throughout the
course of their disease (Department of Veterans Affairs, 2007). VHA HBPC provides
care that is characterized as continuous and comprehensive rather than time-limited
and specific such as home care services provided through other means (Department of
Veterans Affairs, 2007).
The services provided through VHA HBPC are meant to be accessible,
comprehensive, coordinated, longitudinal, accountable, and acceptable (Department of
Veterans Affairs, 2007). Specifically, patient access to providers is available for
emergencies during nights, weekends, and holidays. Comprehensive services are
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holistic in order to treat the majority of the enrollee’s health problems. Coordinated care
provided by VHA HBPC is defined as providing patient referrals to appropriate services,
collaboration and communication to the primary care providers and specialists, and
education about disease treatment and self-care for the patient and caregiver.
Accountable care is described as attention to resource management and providing cost
efficient care. Acceptable care refers to the consent of the patient and caregiver of VHA
HBPC and the willingness to participate in the goals of the individualized care plan
(Department of Veterans Affairs, 2007).
The goals of the program are to promote the Veteran’s health and independence,
reduce the need for hospitalization or other institutional care, assist in transitioning the
Veteran from a health care facility to home, provide support to the caregiver, enhance
the Veteran’s quality of life through symptom management, provide assistance with
chronic disease management, meet the changing healthcare needs of the Veteran, and
provide the option of dying at home (Beales & Edes, 2009). With an interdisciplinary
team monitoring care, greater coordination of services designed to result in an
enhanced level of care continuity. In fact, VHA HBPC incorporates specific features
that have been associated with improved care and reduction in need for hospitalization
among high-risk patients such as frequent in-person contact, acting as a
communications hub, delivering evidence-based education to patients, and providing
timely and comprehensive transitional care after hospitalizations (Brown, Peikes,
Peterson, Schore, & Razafindrakoto, 2012).
The target population of VHA HBPC is Veterans who do not benefit from clinicbased services due to their inability to access services, usually due to their illness or
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disability. Specifically, VHA HBPC targets: those with impaired mobility or functional
limitations which make leaving the home difficult without assistance of another individual;
those who are unable to cope with the clinical environment due cognitive, physical or
psychiatric impairment; those who need frequent, coordinated interventions from
multiple episodes; those who require hospice care for an advanced disease; and those
who experience recurrent hospitalizations or urgent care episodes or are at risk of
nursing home placement and have either congestive heart failure, chronic obstructive
pulmonary disease, a neurological disease, diabetes mellitus, coronary artery disease,
cancer, acquired immunodeficiency syndrome, and/or end-stage liver disease
(Department of Veterans Affairs, 2007).
A description of VHA HBPC enrollees suggests that the average age of enrollees
is 76.7 years, with an average of 19.36 diagnoses that require continuous management,
and take an average of 15 medications per enrollee (Cooper et al., 2007). Furthermore,
many VHA HBPC enrollees are being treated for depression and most have some form
of cognitive impairment (Cooper et al., 2007).
In addition to the targeting criteria, admission requirements for the program
include: living within the VHA HBPC service area; the Veteran and/or caregiver
accepting VHA HBPC as the primary care provider; the determination that the Veteran’s
needs can be met by VHA HBPC; the Veteran has an identified caregiver if determined
necessary by the VHA HBPC team; the home has been determined the most
appropriate place for care as determined by the VHA HBPC team; and the home
environment has been deemed safe for the well-being of the Veteran, caregiver, and
VHA HBPC team (Department of Veterans Affairs, 2007).
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Once enrolled, many Veterans are served by VHA HBPC for the remainder of
their lives. Discharge from VHA HBPC can be for the following reasons: death,
inpatient stay for 16 or more days, a determination that the Veteran can be effectively
treated through routine clinic-based care, the needs of the Veteran exceed the
capabilities of the VHA HBPC team, the Veteran or caregiver request discharge from
the program, the Veteran and/or caregiver do not participate adequately in the treatment
plan, the home environment is considered unsafe for either the Veteran and/or the VHA
HBPC team members, continuation of home care is determined to be unsafe for the
Veteran or caregiver relative to other care options, or the Veteran relocates out of the
service area. If a VHA HBPC enrollee is discharged from the program due to an
inpatient stay of 16 or more days but later is readmitted to VHA HBPC, the complete
interdisciplinary assessment (described below) must be repeated and the Veteran is
treated as new patient.
Services provided in VHA HBPC include primary care, rehabilitation, disease
management, palliative care, and coordination of care. An interdisciplinary team is in
place to provide the necessary services and includes a physician medical director, a
program director, and staff from nursing, social work, rehabilitation, dietetics, and
pharmacy. Other services often needed include pastoral and mental health services.
Every VHA HBPC program has a minimum of 3 full time, direct care nursing staff
members, but the specific staffing mix is specified such that the VHA HBPC team must
be able to meet the needs of the patient population (Department of Veterans Affairs,
2007).
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Case loads are determined at the local level and usually range between 20 to 30
patients to each registered nurse or licensed practical nurse, 80 to 105 per social
worker, 85 to 155 per rehabilitation therapist, and 95 to 125 per dietician (Department of
Veterans Affairs, 2007). Teams meet weekly to discuss patients and determine care
plans. The frequency of home visits are based on the Veteran’s needs and clinical
judgment (Department of Veterans Affairs, 2007).
Veterans can be referred to VHA HBPC from any care setting as long as the
primary care provider concurs with VHA HBPC being an appropriate mode of care for
the Veteran. Once referred, the Veteran must be evaluated by at least one member of
the VHA HBPC program to determine if the home environment is appropriate for VHA
HBPC. Once this determination is made, the Veteran is assessed in their home by at
least three team members specializing in different disciplines. Assessment includes
health history, physical, psychosocial, financial, cultural, spiritual, nutritional, functional,
home environment, and pain symptomology. The members of VHA HBPC formulate
individualized treatment plans based on the Veteran’s and caregiver’s needs. If
services are received outside of the VHA HBPC team, VHA HBPC adopts a medical
management and care coordination role. The treatment plan is modified as needed and
reviewed at least every 90 days (Department of Veterans Affairs, 2007).
VHA HBPC collaborates with services that cannot be provided through the direct
care staff of the VHA HBPC team. These services can include mental health services,
short-term respite, personal care, skilled home care that is beyond the scope or
frequency of VHA HBPC, palliative care, care coordination, home telehealth to expand
the geographical reach of the program, volunteer services, and other VHA services that
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enable appropriate management of VHA HBPC patients (Department of Veterans
Affairs, 2007). These ancillary services can be provided through VHA or through
Medicare if the Veteran is enrolled in Medicare. The Veteran has the ultimate right to
choose where to receive services but the VHA must offer to pay for contracted care or
provide the necessary services (Department of Veterans Affairs, 2005, 2007, 2008).
Evidence on VHA HBPC. Several studies have examined the VHA HBPC
program including both descriptive and quantitative analyses. Below is an overview of
these studies, followed by a discussion of the limitations and remaining questions
regarding VHA HBPC.
Patient outcomes associated with VHA HBPC. An early randomized study of
VHA HBPC among those with severe disabilities or who were terminally ill was
conducted utilizing data from 1984 through 1987 from the Hines, Illinois VHA hospital.
Survival was similar in both VHA HBPC patients (124.6 days) and the control group
(128.2 days) (Cummings et al., 1990). To determine differences in patient outcomes,
multivariate analysis of covariance indicated that there were no differences between the
groups in terms of ADL functioning, cognition, or patient morale at one or six months
following baseline (Cummings et al., 1990). However, differences were found at one
but not six months after baseline for patient satisfaction with VHA HBPC recipients
reporting significantly higher levels of satisfaction with care compared to controls
(Cummings et al., 1990).
Another early analysis of the Hines, Illinois VHA hospital’s HBPC program
indicated that there were no differences between the terminally ill enrolled in VHA
HBPC compared to a randomized comparison group in terms of ADL limitations,
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cognitive status, or morale at one month from baseline but found that VHA HBPC
enrollees had higher patient satisfaction at one month (p = .02), although this difference
was not maintained through the six month evaluation (Hughes et al., 1992). This study
also examined survival days and found that VHA HBPC recipients were not different
than the control group (76.2 days vs. 83.1 days) (Hughes et al., 1992). However,
survival time revealed a marked difference (i.e., shorter duration) from the earlier
examination of survival time among terminally ill patients at the same VHA medical
center (Cummings et al., 1990).
A later and larger study of 16 VHA HBPC programs found that patients with a
terminal diagnosis who were enrolled in VHA HBPC had significant improvement in
health-related quality of life compared to those in the control group (Hughes et al., 2000).
However, there was no difference in health-related quality of life between groups among
the non-terminally ill (Hughes et al., 2000). Among terminal patients, there was no
difference found in patient satisfaction among those enrolled in VHA HBPC compared to
terminal patients not in VHA HBPC (Hughes et al., 2000). There was, however, a
significant increase in patient satisfaction among nonterminal patients in VHA HBPC
(Hughes et al., 2000). Similar to these earlier studies, a recent study interviewed 31
newly enrolled VHA HBPC recipients who reported high levels of satisfaction with VHA
HBPC team access, education, and continuity of care (Edes et al., 2014).
Service use associated with VHA HBPC. Cummings et al. (1990) found that
those receiving VHA HBPC were more likely to receive visits from a physician, physical
therapist, social worker, and home health aide and/or dietician compared to a
randomized control group receiving usual care even despite both groups receiving

19

similar number of service visits on average (22.8 for VHA HBPC enrollees compared to
21.7 for controls). The number of days receiving of home care was significantly greater
for those in VHA HBPC compared to the control group (98 vs. 79 days, respectively)
(Cummings et al., 1990). Number of days spent in a VHA hospital did not differ
significantly by group although there was a difference in time in specific hospital wards.
VHA HBPC recipients spent a higher proportion of their time on the intermediate care
ward and less time on the general care wards compared to the control group
(Cummings et al., 1990). Outpatient service utilization differed significantly with VHA
HBPC recipients receiving fewer outpatient clinic visits (1.33 visits compared to controls
3.39 visits) (Cummings et al., 1990). The authors concluded that the program was not
associated with adverse outcomes and resulted in marginal reductions in hospital length
of stay.
In another analysis, the Hines VHA study of the terminally ill in VHA HBPC, found
that there was a significant decline in number of hospital days, from an average of 15.9
days prior to enrollment to an average of 10 days and VHA HBPC enrollees spent an
average of 3.5 fewer days in the hospital immediately prior to death compared to the
randomized control group receiving usual care (Hughes et al., 1992). There were also
differences in the number of outpatient clinic visits by group with VHA HBPC patients
having significantly fewer outpatient visits although VHA HBPC recipients had
significantly more home visits from a nurse compared to controls (Hughes et al., 1992).
A larger study of 16 VHA HBPC programs by Hughes et al. (2000) found a
relative reduction in the proportion of VHA HBPC enrollees who were admitted to the
hospital in the first six months, but the reduction was not retained at 12 months.
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Additionally, a relative reduction in hospital readmissions was found only at six months
among those enrolled in VHA HBPC (Hughes et al., 2000). There was also not a
significant difference in the number of hospital days among re-hospitalizations between
the VHA HBPC and control groups (Hughes et al., 2000).
Chang, Jackson, Bullman, and Cobbs (2009) assessed 183 VHA HBPC
enrollees from the Washington, DC program who were in the program for at least six
months during 2001 to 2002 and found that there was a significant decrease in the total
number of hospitalizations (-43.7% change) and the total number of days in the hospital
(-49.9% change) after enrolling into the program compared to prior to enrollment.
However, they did not find a significant difference in the total number of emergency
department visits (-18.5% change, non-significant) after enrollment into VHA HBPC
(Chang et al., 2009).
In an analysis of a Missouri VHA HBPC program that specifically targeted those
in advanced stages of chronic heart failure and chronic obstructive pulmonary disease,
it was determined through linear regression that actual hospitalization days were 7.5
days per patient per six months less than expected (p < .001) (Edes, Lindbloom, Deal, &
Madsen, 2006).
Cost associated with VHA HBPC. A cost analysis was conducted on the
Missouri VHA HBPC program that targeted those in advanced stages of chronic heart
failure and chronic obstructive pulmonary disease. It was found that those enrolled in
VHA HBPC produced a cost savings of $1,873 per patient per month based on reduced
services use including a reduction in hospital days after enrollment in the program
compared to pre-enrollment (Edes et al., 2006). This was based on the difference of

21

the cost of services prior to enrollment versus during enrollment by calculating the sum
of the median number of hospital days (decrease from 7.5 to 1), median ancillary
outpatient visits (decrease from 10 to 7), median allied health outpatient visits (3, no
change), primary and specialty care visits (decrease from 9 to 6), and the VHA HBPC
visits (increase from 0 to 6). Similarly, another more recent analysis was conducted
comparing expected costs to actual costs for 9,425 newly enrolled VHA HBPC
recipients which found that Medicare costs were 10.8% lower than projected, VA plus
Medicare costs were 11.7% lower than expected, and combined hospitalizations were
25.5% lower than prior to VHA HBPC enrollment (Edes et al., 2014).
These findings supported the early randomized cost effectiveness study that
determined that VHA HBPC produced a net savings of 13% compared to those in usual
care (Cummings et al., 1990) and another study that suggested that VHA HBPC
produced a net savings of 18% (albeit non-significant difference) among those
diagnosed with a terminal condition with a 6-month prognosis (Hughes et al., 1992).
Although those in VHA HBPC had significantly more home health care than the
comparison group which more than doubled the cost of home care ($658 more in 1985
dollars), the savings were attributed to lower VHA (48% lower) and private sector
hospital costs over a six month period and to lower institutional care costs for those
enrolled in VHA HBPC (Hughes et al., 1992). Based on the differences in rates of
utilization, these findings on cost differences were expected.
Another cost analysis finds different results than the four aforementioned studies.
The analysis of 16 VHA HBPC programs found that total costs among those enrolled in
VHA HBPC were 6.8% higher compared to the randomized control group. Even though
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the costs among the VHA HBPC group were lower for hospital readmissions and private
sector costs, home-based care and nursing home costs were significantly higher
compared to the control group (Hughes et al., 2000). The only sector identified as
significantly reducing cost among the VHA HBPC group was outpatient services
(Hughes et al., 2000).
These disparate findings could be a result of the differences between VHA HBPC
programs and differences in study designs. The majority of studies that found cost
savings were single-site studies, whereas, the higher cost findings were found among
the study of 16 VHA HBPC programs. These differences support the need for further
research that includes multiple VHA HBPC sites.
Other research on VHA HBPC. Other research suggested that VHA HBPC
enrollees could benefit from in-home pharmacy evaluations to increase adherence to
medication compliance (Hsia Der, Rubenstein, & Chov, 1997). Recently, VHA HBPC
patient records were used to determine the applicability of using the Medication
Appropriateness Index to monitor medication adherence, efficacy, and adverse events
(Davis, Hepfinger, Sauer, & Wilhardt, 2007).
Another study examined the characteristics associated with VHA HBPC
enrollment among those with mental health diagnoses. It was determined that VHA
HBPC enrollees with mental health diagnoses are more likely to be older, male,
divorced, separated, or widowed, suffer greater service-related disability, have a VA
pension, and have higher incomes compared to those that did not utilize VHA HBPC
(Miller & Rosenbeck, 2007). It was also found that VHA HBPC enrollees with mental
health diagnoses were less likely to be diagnosed with drug abuse or dependence but
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were more often diagnosed with all other mental health diagnoses, most commonly
Alzheimer’s disease or dementia (Miller & Rosenbeck, 2007). VHA HBPC enrollees
with mental health diagnoses had greater morbidity and were more likely diagnosed
with chronic conditions like hemiplegia/paraplegia, diabetes, mild liver disease,
rheumatologic disease, chronic pulmonary disease, cerebrovascular disease, and
congestive heart failure (Miller & Rosenbeck, 2007).
Limitations of the evidence on VHA HBPC. Based on these data, VHA HBPC
seems like a promising model of care, but worthy of further investigation. A number of
limitations are evident within the existing literature. Specifically addressing the evidence
on cost effectiveness, two of the studies (Cummings et al., 1990; Hughes et al., 1992)
were conducted prior to the availability of cost data in VHA administrative patient
records (1984-1987), had relatively small samples (N=171 and 419, respectively), and
utilized only local data. Hospital costs were based on 1985 average accounting costs
per day. Moreover, in the Edes, et al. (2006) study, cost savings from intensive care
units and emergency departments were assumed to be zero and the sample size was
34 patients.
The evidence that suggested VHA HBPC is associated with fewer hospital days
and number of hospitalizations should also be considered limited. First, the Hughes et
al. (1992) study uses local data from the 1980’s with a small sample size. Second, the
Edes et al. (2006) study reported a reduction of ICU and ED use based on a regression
using data from only 34 patients. Additionally, the confidence intervals raise doubt
regarding the conclusions that can be drawn from this evidence. Moreover, the time
examined was based on 120 days after enrollment compared to two years prior to

24

enrollment. Chang et al. (2009) based their findings on local data which only measured
six months pre- and post-enrollment, used only t-tests, and did not have a comparison
group. Finally, patient outcomes in terms of survival time were determined based on
simple means tests without covariate accountability.
There are several reasons why the above limits the evidence on the
effectiveness of VHA HBPC. First, when studies use only a pre-post design and do not
have a control or comparison group, there could be selection bias in the sample.
Selection bias can undermine the findings due to prior group differences that existed in
the selected sample rather than differences based on participation in VHA HBPC. This
is why a comparison group, at a minimum, is vital to understanding a program’s effects.
Using simple averages to determine patient outcomes in terms of survival does
not take into account the multitude of factors that affect survival. Several techniques,
like regression-based survival analysis, take into account not only the time until event,
but also accounts for covariates that can potentially confound the relationship between
the entry into the observation period and the event. Likewise, more robust statistical
estimations are needed to confirm the earlier findings using national data. Therefore,
the current literature regarding VHA HBPC’s impact on service use, cost, and survival
remain unclear. Thus, the current study aims to expand the evidence associated with
VHA HBPC by using national data with a comparison group to examine service
utilization, average total expenditures, and survival.
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Chapter 2: The Present Study
The overall goal of the proposed study is to determine the impact of VHA HBPC
on service utilization, expenditures, and survival. This section describes the study
objectives, the logic model used to develop the hypotheses, and the theoretical
framework used to conceptualize the relationship between the factors of interest.
Finally, the aims and corresponding hypotheses are conveyed.

Objectives
Although evidence exists regarding the effectiveness of VHA HBPC, more
research is needed. The current study aims to accomplish three objectives. First, this
study will examine the effect of VHA HBPC on major healthcare service use (i.e.,
hospital, nursing home, and outpatient care) paid for by the U.S. Department of
Veterans Affairs (VA).2 Next, this study will examine the effect of VHA HBPC on total
expenditures paid for by the VA. Third, this study will examine whether VHA HBPC
enrollees experience similar mortality and survival as compared to a matched
concurrent cohort.
This study is critical due to the rise in the number of Veterans that are
homebound from traumatic brain injury, mental health issues, and spinal cord injuries,
which is likely to increase the demand for VHA HBPC. Although current evidence
describes the VHA HBPC population as generally older with chronic comorbid
2

The VA is comprised of three sectors: the Veterans Health Administration (VHA), the Veterans Benefits
Administration, and the National Cemetery Administration. Reference to the VA refers to the Department
as a whole whereas reference to the VHA refers specifically to the Veterans Health Administration.
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conditions, the proposed study is significant to improving the care received by young
and old Veterans alike who need medical care in the home.
In addition to the overall effect of VHA HBPC on service use, cost, and survival,
this study will look at specific strata including those age 85 and older, those with two or
more comorbidities, and those who were diagnosed as recipients of palliative care. The
following describes the rationale for these specific examinations.
Older Adults and VHA HBPC. It is well-understood that healthcare costs
increase dramatically for older adults who are approaching the end of life, often due to
substantial disease burden and aggressive attempts to treat complex medical conditions
(Chastek et al., 2012; Frederix et al., 2013; Hogan, Lunney, Gabel, & Lynn, 2001; Yu,
Smith, Kim, Chow, & Weaver, 2008). Conversely, other research suggests that older
age is associated with less aggressive end-of-life care (Miesfeldt et al., 2012), including
lower rates of hospitalizations (Menec, Lix, Nowicki, & Ekuma, 2007). The average age
of VHA HBPC enrollees is 76.7 years (Cooper et al., 2007), and therefore, it is important
to examine the effect of VHA HBPC by those who are the oldest old.
Comorbidity and VHA HBPC. Comorbid conditions are common in the general
population and resource use has been associated with the degree of comorbidity rather
than the specific diagnosis (Starfiled et al., 2003). Moreover, research suggested that
comorbidity mediates the role between age and survival (Jung et al., 2012). Given the
average age of VHA HBPC enrollees and considering that the average VHA HBPC
enrollee has 19.36 diagnoses that require continuous management (Cooper et al.,
2007), degree of comorbid conditions should be considered in this investigation.
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Hospice and VHA HBPC. Throughout the last decade, the VHA has focused
on increasing access to hospice care through a variety of initiatives which resulted in an
increase in the number of inpatient deaths in hospice bed sections and an increase in
referrals to community hospice providers (Department of Veterans Affairs, 2011). The
implications of the increased use of hospice care among VHA HBPC enrollees are
important given that hospice care has been associated with decreased health care
costs near the end of life in some studies (Brumley et al., 2007; Kelley, Deb, Du,
Carlson, & Morrison, 2013; Penrod et al., 2010) and an increase in others (Emanuel et
al., 2002; Pyenson, Connor, Fitch, & Kinzbrunner, 2004).
Considering that those who are receiving hospice would have different health
service patterns as a result of this service and that many of the previous studies on VHA
HBPC selected a sample that included only those with terminal illnesses, it is necessary
to examine the effect of VHA HBPC by identifying those that received such services.
Additionally, this type of examination is needed given that many die while enrolled in
VHA HBPC.

Logic Model
The logic model presented here proposes that a vulnerable population who
needs healthcare services due to a variety of comorbidities and disability, experience
disease exacerbation, a lack of disease management, and a lack of coordination of care
without VHA HBPC (Figure 1). This population is in need of services but cannot leave
the home to access those services. Therefore without VHA HBPC, service use, such as
avoidable hospitalizations and nursing home use, increases along with expenditures.
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This logic model assumes that the intervention of VHA HBPC will help patients manage
their diseases and symptoms and receive the necessary coordination of care that is
associated with a decrease in avoidable services, e.g., hospitalizations, which should
decrease expenditures. This logical model stems from Andersen’s behavioral model,
described below.

Without VHA HBPC

Vulnerable
population
unable to
access care*

Disease
exacerbation,
lack of disease
management
& coordination
of care

Higher resource
use and
expenditures

Symptom and
disease
management,
coordination of
care

Decrease avoidable
hospitalizations
and nursing home
use which should
decrease
expenditures

With VHA HBPC

Vulnerable
population
unable to
access
care*

The point at which
VHA HBPC intervenes
on health behavior.
Figure 1. Logic Model to Understand Why One Should Expect VHA HBPC to
Decrease Service Utilization and Cost.
*This model is influenced by Andersen’s behavioral model, discussed below.
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Theoretical Framework: Andersen’s Behavioral Model
Andersen’s (1973) behavioral model is a model frequently applied to health
service research and can be applied as a framework for the current investigation. This
model is comprised of three determinants that explain health services utilization. The
first of these determinants is predisposing characteristics which include demographic
characteristics (e.g., age, sex, and race). The basic notion related to predisposing
characteristics is that some individuals with certain characteristics will be more likely
than others to use health services regardless of the fact that these predisposing
characteristics are not directly related to health services.
The second determinant is referred to as enabling resources. Enabling
resources include family (e.g., income, health insurance) and community characteristics
(e.g., price of health services, ratio of health personnel to the population). Specifically,
individuals must have the means to receive services. Additionally, access to health
facilities and the appropriate personnel have to be available in order for persons to
receive services. As such, these factors can either enable or prohibit an individual’s
receipt of health care services. For example, a study found an association between
disparities in physician utilization and enabling factors (i.e., level of income and health
insurance status) after adjusting for predisposing factors and need for care (Blackwell,
Martinez, Gentleman, Sanmartin, & Berthelot, 2009).
The final determinant to explain health services utilization is need and the
perceived need for healthcare. How individuals view their health, how they experience
health symptoms, and the ideas they attach to this experience is of importance when
considering health services utilization. For example, research underscores the
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importance of the need of services when determining service use for bereavement
services (Bergman, Haley, & Small, 2011). Additionally, awareness of unmet needs has
been linked to the use of home- and community-based service utilization (Chen &
Thompson, 2010). Finally, Elhai et al. (2008) found that predisposing and enabling
factors were associated with outpatient utilization among Veterans, but need factors
provided an additive effect over predisposing and enabling variables accounting for the
strongest effects.

Predisposing Factors
Race

Age

Sex

Enabling Factors
HBPC

Geographic
location

Need Factors
Complex,
Chronic
Conditions

Hospice/
Palliative
care
Insurance
Status

OUTCOMES
Health Services Use

Health Services Cost

Mortality

Figure 2. Health Behavior Model for VHA HBPC
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Predisposing Factors. The typical enrollee of VHA HBPC has characteristics
that are commonly associated with those that have complicated post-hospital transitions
of care (Kind, Smith, Frytak, & Finch, 2007) which can lead to higher service use such
as being older, male, and African American (Chang et al., 2009; Hughes et al., 2000).
Therefore, age, race, and sex will be accounted for in this study.
Enabling Factors. VHA HBPC enrollment in itself could be an enabling factor
associated with healthcare use. Related to VHA HBPC enrollment is geographic
location. While almost all VA medical centers offer VHA HBPC, living within a specified
distance of these services could affect access to services. Research on Veterans
suggests that rurality status is associated with service use and medical costs (Bailey,
Manning, & Peiris, 2012). Additionally, insurance status has been linked to physician
utilization (Blackwell et al., 2009). In this case, VHA service connectedness serves a
proxy for insurance status. Service connectedness influences the amount of cost-share
the Veteran can expect when utilizing services and is based on service history and
disability status.
Furthermore, hospice, by philosophical and regulatory definition, is associated
with less aggressive care at the end of life. For example, in a study examining
emergency department use among those age 65 and older from 1992 to 2006, it was
found that those that utilized hospice at least one month prior to death were rarely
admitted to the emergency department (Smith et al., 2012). Therefore, hospice care
could be considered an enabling, or more appropriately in this case, a prohibiting factor
associated with certain types of care. For these reasons, palliative care (in place of
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hospice3), geographic location, service connectedness or eligibility (in place of
insurance status), and likelihood of VHA HBPC enrollment will be accounted for in this
analysis.
Need Factors. Need is particularly important in an older Veteran population
which has experienced an increased clinical complexity and dependency compared to
age-matched non-Veterans (Shay & Burris, 2008). Additionally, those enrolled in VHA
HBPC are by enrollment criteria, those who are in need of healthcare services.
Therefore, comorbidities will be used as a proxy for need of services in this study.

Aim 1
This study will examine the effect of VHA HBPC on health service utilization.
Hypothesis 1. It is expected that VHA HBPC will have an effect on health
service utilization by decreasing nursing home use and acute hospitalizations and by
increasing outpatient service utilization.

Aim 2
This study will examine the effect of VHA HBPC on total healthcare expenditures
paid by the VA.
Hypothesis 2. It is expected that VHA HBPC is associated with lower total
healthcare expenditures due to expected decreased nursing home use and acute
hospitalizations.
3

Hospice care is compassionate care for those facing a life-limiting illness or injury provided through a
team approach to medical care, pain management, and emotional and spiritual support specific to the
patient’s preferences (National Hospice and Palliative Care Organization, n.d.-a). Palliative care is
patient and family-centered care that anticipates, prevents, and treats suffering throughout the continuum
of the illness addressing physical, intellectual, emotional, social, and spiritual needs (National Hospice
and Palliative Care Organization, n.d.-b). A distinguishing characteristic between these two related types
of care is that palliative care can be provided concurrently with curative or life-prolonging care.
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Aim 3
This study will examine if there is a survival differential associated with VHA
HBPC enrollment.
Hypothesis 3. It is expected that VHA HBPC is associated with differential
survival.

Method
Data Sources. The VHA system is ideal for examining service utilization and
expenditures because of the fact that all VHA healthcare providers are part of a
centralized reporting system which makes the VHA the single largest integrated
healthcare system in the U.S. Specifically, the Veterans Integrated Health Systems and
Technology Architecture, or VISTA, is the health information system that captures
information on daily operations at all VHA facilities for both inpatient and outpatient
services at the patient level through the use of electronic health records. VISTA is
decentralized but data is extracted from VISTA to create national datasets (Barnett,
2003).
Decision support system (DSS). The extracted VISTA data is the main source
for the database referred to as DSS. DSS is an activity-based allocation system which
uses DSS Identifiers, also referred to as “stop codes” to collect workload information,
support patient care continuity, resource allocation, performance measurement, quality
management, and third-party collections (Veterans Health Administration, 2008). This
coding system has been nationally implemented since 1999 and indicates who provides
specific clinic products.
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DSS Identifiers are six digits comprised of a primary and secondary coding
scheme. The first three digits (i.e. the primary code) indicate the type of services
provided followed by the second three digits (i.e. the secondary code) which indicate the
secondary modifier. These codes were used to identify VHA service utilization and
expenditure information at the patient level from inpatient and outpatient files.
Purchased care files. The VA makes payments to non-VHA providers when
care is needed for a Veteran that the VHA cannot provide. This information is
accessible from the Purchased Care files, formerly known as the Fee Basis files. This
study utilized inpatient purchased care files to determine non-VHA acute
hospitalizations that were paid for by the VA. Patient identifiers enable merging across
data files.
Vital status file. The VHA Vital Status Files contains mortality data from multiple
VHA and non-VHA sources (i.e., Medicare Vital Status File and the Social Security
Administration) (Veterans Health Administration, 2014). The file contains information
including social security number, date of birth, gender, and date of death.
Measures. The following are operationalizations of the variables in this study.
VHA HBPC. VHA HBPC enrollees were identified through DSS by the utilization
codes of 156 (psychologist), 157 (psychiatrist), and 170-177 (physician; registered
nurse, registered nurse practitioner, physician assistant, or licensed practical nurse;
nurse extender or physician extender; social worker; therapist [recreation, physical, or
occupational]; dietician; clinical pharmacist; telephone; other). VHA HBPC status was
dichotomized (1=VHA HBPC enrollee, 0=not enrolled in VHA HBPC) and used as a
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treatment indicator to determine associations with health services utilization,
expenditures, and survival.
Initial treatment date. To determine when to start analyzing the use and cost of
services, the initial treatment date was used as day one. For the treatment group, the
initial treatment date was the first date of VHA HBPC utilization. For the comparison
group, the initial treatment date was the first date of an outpatient utilization after the
beginning of the study period (the first day of FY 2009, i.e., October 1, 2008).
Healthcare utilization. Health services were categorized into nursing home care,
acute hospitalizations (VHA and non-VHA), and outpatient utilizations. These variables
were constructed separately as dichotomous variables (yes/no). Additionally, counts of
service utilization were constructed for hospitalizations and for outpatient utilizations.
Hospitalization was determined by a claim for inpatient utilization.
Hospitalizations were included in the analysis if they occurred after the initial treatment
date and before the end of the study period (i.e., September 30, 2012).
The number of past hospital utilizations was identified by inpatient hospitalization
codes in FY 2008 and was used in the case/control matching technique (values were
binary indicators of 1, 2, or 3 or more with zero past hospitalizations being the reference
category). The number of hospitalizations after the initial treatment date were calculated
as an outcome variable.
Nursing home utilization was identified through the outpatient files (values 650,
651, 653, and 654). Nursing home utilization was included in the analysis if utilization
occurred after the initial treatment date and before the end of the study period
(September 30, 2012).
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Palliative and bereavement care. Considering that many VHA HBPC users are
in the program at the end of life, ICD-9-CM procedure codes were used to determine
use of palliative care (V66.7) or bereavement services (V62.82). The utilization of
hospice care was considered but the data were not ideal to examine hospice use.
Therefore, the use of the ICD-9-CM code V66.7 was used as a proxy for recipients of
hospice care since hospice-specific codes weren’t implemented throughout the VHA
until FY 2012. Also, because such codes could be associated with the likelihood of
death, they were identified as separate binary indicators and used to predict VHA HBPC
treatment in the case/control matching technique. Up to 20 ICD-9-CM primary
diagnosis codes, sourced from the outpatient file, were used to determine the receipt of
palliative care or bereavement services.
Expenditures. Cost information for care provided by the VHA is available
through DSS. These costs are considered total costs of care (i.e., direct and indirect).
The Purchased Care files also contain cost information for the amount the VA paid for
non-VHA inpatient utilization, which were also included in this study. Cost information
was constructed separately for VHA-provided services including hospital, nursing home,
and outpatient services, and for non-VHA provided inpatient hospital services. These
services were summed to determine total cost of care.
Demographics. All demographic variables were identified by DSS, including age,
race, and service eligibility. Age was defined in years and represents baseline age. Sex
was identified based on the dichotomous variable sex from the VHA Vital Status File
and outpatient DSS files.
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Race was derived from outpatient DSS files and was defined as: Black or African
American, White, and other. Additional categories of race and ethnicity were available
but these groupings had numbers too small to be informative in the analysis and were
therefore categorized as other. Due to the high rate of missingness on the race variable,
a ‘missing race’ category was created in order to retain all available information and
cases in the analyses while maintaining the integrity of the race values that were
available. Dummy indicators were constructed for Black, other, and missing, with white
as the reference category.
Veteran eligibility is based on categories representing the degree of disability
related to serving in the service and the degree of impairment. Not being service
connected was compared to all other eligibility categories as a binary indicator.
Geographic location was considered for the model, but a recent study suggested
that distance from a VHA medical center was an effective instrumental variable for
determining the risk of hospitalization (Edwards, Prentice, Simon, & Pizer, 2014).
Instrumental variables are not recommended for use in matching algorithms. Therefore,
geographic location was not included, but was examined after the matches were
selected and the determination was made that there was not a significant difference
between the treatment and comparison groups in miles to the nearest VHA medical
center offering VHA HBPC.
Comorbidity. The DSS variable ‘Primary Diagnosis’ uses ICD-9-CM codes to
discern patient morbidity. Up to 20 ICD-9-CM codes, sourced from the outpatient file at
baseline, were used to determine patient comorbidity. The ICD-9-CM codes used in this
analysis were identified at baseline and were constructed into separate binary indicators
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based on the Elixhauser method (Elixhauser, Steiner, Harris, & Coffey, 1998). While
other methods of measuring morbidity exist, the Elixhauser method has shown superior
performance compared to others, such as the Charlson index (Southern, Quan, & Ghali,
2004). The mutually exclusive morbidity categories used here were: congestive heart
failure, cardiac arrhythmia, valvular disease, pulmonary circulation disorders, vascular
disorders, hypertension uncomplicated, hypertension complicated, paralysis,
neurological disorders, chronic pulmonary disease, diabetes, hyperthyroidism, chronic
kidney disease/renal failure, liver disease, lymphoma, metastatic cancer, cancer without
metastasis, rheumatoid arthritis/collagen, coagulopathy, weight loss, obesity, anemia,
alcohol/drug abuse, psychoses, and depression. A separate variable was created to
account for comorbidity by identifying if a patient had two of more of any of the
Elixhauser categories.
Mortality. The date of death for subjects in this study was ascertained from the
VHA Vital Status File. To examine survival, the difference between the initial treatment
date and the date of death was calculated. If death did not occur, survival time
represented the difference between the initial treatment date and the end of the study
period (i.e., September 30, 2012).
Study Design. In order to examine the impact of VHA HBPC, a retrospective
cohort design was utilized. The cohort under investigation was selected from FY 2009
and FY 2010 (i.e., the baseline period) and was followed through FY 2012.
Similar to another recent examination of VHA HBPC (Edwards et al., 2014), the
treatment (VHA HBPC) cohort was selected by identifying patients who had more than
one VHA HBPC utilization during the baseline period. If there was only one VHA HBPC
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utilization, the patient was not considered a VHA HBPC participant, and thus, was a
potential control. This is because having only one utilization likely indicates an
assessment for VHA HBPC that did not result in program enrollment. Additionally, to be
included in the treatment cohort, VHA HBPC enrollees had to be first-time participants
in the program, determined by a two year look back which identified those who had VHA
HBPC utilization during FYs 2007 or 2008. These cases were removed from the
analyses.
All covariates (i.e., demographics, clinical characteristics, and frequency of past
hospitalizations) were selected at baseline and compared by treatment status to
determine if bias was present based on participation in VHA HBPC. In this study, all
covariates were used as binary indicators, and therefore, were compared using chisquare goodness-of-fit tests. As will be described in detail in the results, all but one of
the covariates were significantly different based on participation in VHA HBPC. These
baseline differences between groups necessitated the control for confounding by the
use of propensity matched scores to identify an appropriate comparison group.
Propensity matching uses predicted probability of group membership obtained
from a logistic regression model based on observed predictors. Propensity matching
reduces the imbalance of the observed baseline characteristics between two groups by
matching individuals based on the probability of exposure to the treatment, in this case,
participation in VHA HBPC. Various methods of utilizing propensity scores exist (e.g.,
stratification based on the propensity score, regression adjustment, inverse probability
weighting), but matching based on probability of treatment is believed to produce more
precise estimates compared to other methods (Austin, 2007).
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Since selecting a propensity method is somewhat subjective, a review of
propensity score methods was conducted and it was concluded that matching is
recommended when the data are appropriate for this method (Austin, 2007, 2009b,
2014). Other methods have limitations including extreme weights being common with
inverse probability weighting which could be due to violations of the positivity
assumption (Vittinghoff, Glidden, Shiboski, & McCulloch, 2012). Additionally,
stratification of the propensity score can cause residual confounding (Vittinghoff et al.,
2012), has been shown to produce the greatest bias, and is not recommended for use
with time-to-event outcomes (Austin & Schuster, 2014). Type I errors tend to be higher
in methods other than matching (Austin & Schuster, 2014). Therefore, although there is
subjectivity in the selection of the method of propensity score modeling, matching is
highly regarded and recommended if the data and study design are appropriate, as was
the case in this study. Given this, and the robustness of the data, the matching
technique was selected.
Statistical Analysis. All analyses were conducted in SAS 9.2 (SAS Institute Inc.,
2009).
Sample. In this study, to generate patient-specific propensity scores to determine
probability of participating in VHA HBPC, a multivariate logistic regression was used.
All observed covariates that were predicted to be associated with the outcomes were
included in the model, i.e., all covariates previously described. Specifically, these
included: age (in years: 65-74, 75-84, 85-111; reference category: 0-64 years), sex
(male=1), race (Black, other, missing; reference category: white), 25 comorbidities
(dichotomous indicators), the number of comorbidities (two or more compared to less
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than two), select ICD-9-CM procedures (i.e., palliative care and bereavement), and
service eligibility (not service connected compared to all other eligibility, dichotomized).
All variables were binary.
After the propensity scores were generated via multivariate logistic regression,
the population was then randomly sequenced and matched one control to one treatment,
which is the recommended number of case-controls (Austin, 2010), without
replacement,4 using nearest neighbor5 matching with a caliper6 distance of 0.20 of the
standard deviation of the logit of the propensity score. The caliper distance of 0.20 of
the standard deviation of the logit of the propensity score has been validated as yielding
optimal performance when estimating treatment effects (Austin, 2009b; Y. Wang et al.,
2013). By applying a caliper parameter to the match, the proportion of the standard
deviation of the logit of the propensity score is defined. In other words, if the standard
deviation of the control is more than 0.20 from the standard deviation of the logit of the
propensity score of the treatment case, it is not selected as a match. The random
generation will continue to the next randomly selected case and determine if the
propensity score is within the selected 0.20 allowable range. This process continued
until all cases were matched to controls.
Next, the distributional probabilities of cases and controls were compared to
determine that the overlap assumption was met to allow for the analysis of outcomes

4

Without replacement indicates that matched controls cannot be placed into the pool of potential controls
to be matched for another treatment case (Stuart, 2010). In other words, each matched control is a
unique case.
5 Nearest neighbor refers to selecting a case from the control group that is closest to, i.e. smallest
distance from, the propensity score of a treatment case (Stuart, 2010).
6

A caliper refers to the fixed allowable distance between the treatment case and the matched control
case (Stuart, 2010).
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between comparable groups. To do this, the distribution of the propensity scores were
examined by VHA HBPC status. Then, the distributions of the observed covariates
were checked by evaluating standardized differences by VHA HBPC status to confirm
that the propensity scores created a balanced distribution between groups, of which,
less than 10% is considered balanced (Austin, 2009a). After ensuring the overlap
assumption was met, analyses of the outcomes were conducted.
Aim 1. Healthcare services were analyzed by VHA HBPC status using
descriptive statistics to indicate the rates of utilization. McNemar’s test of significance
was applied to determine if there was a statistically significant difference between VHA
HBPC status and service utilization. McNemar’s test was necessary to account for the
matched study design.
In this analysis, multivariate statistics were not necessary to determine whether
VHA HBPC enrollment significantly impacted healthcare service utilization since all
covariates have been adjusted by the use of propensity score matching. Furthermore,
previous research suggested that samples generated via propensity score methods can
result in biased estimation of conditional odds ratios, like those produced by logistic
regression models (Austin, 2007). Austin et al. (2007) posited that when using matched
samples based on propensity scores, odds ratios produce sub-optimal performance
whereas methods that measure differences in proportions or means have superior
performance over odds ratios. Therefore, relative risks are recommended in propensitymatched studies since these methods outperform odds ratios in the decrease of the
mean-squared errors.
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Relative risks were calculated for each service category. By utilizing this type of
study design and analysis, the results allowed conclusions to be drawn as to the
association between VHA HBPC enrollment and specific types of service utilization
relative to the comparison cohort.
Aim 2. Descriptive statistics were used to indicate how VA expenditures varied
by VHA HBPC status by describing total average expenditures over the duration of the
study period and by describing average expenditures specifically by nursing home care,
hospitalization (VHA and non-VHA), and outpatient utilization.
Then, generalized linear models (GLM) with gamma link and log functions were
used to examine whether there was a statistically significant difference in the average
cost of care by VHA HBPC status. This modeling technique was appropriate for
healthcare expenditures due to the nature of heteroscedasticity and skewness in the
cost distributions while retaining the original dollar scale of the data (Blough & Ramsey,
2000). The models were weighted based on how many days each individual was
observed in the study.
Aim 3. To determine if there was a significant difference in survival by VHA
HBPC status, bivariate relative risk analysis was first conducted. Then, the examination
of survival (i.e., dead or alive) time (in days) by VHA HBPC status was determined by
utilizing a Cox proportional hazards model. In the current study, observations were right
censored which was accounted for by the Cox proportional hazards model. Since this
time-to-event analysis was conducted using the matched sample which adjusted
confounding factors, the only additional adjustments made in the Cox regression model
were exposure to treatment (i.e., participation in VHA HBPC) and quintile of the logit of
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the propensity score. A robust estimator of variance is used to account for the lack of
independence between groups due to clustering from matching. The event in this study
is death (=1) or survival (=0). The origin of time was based on the initial treatment date.
Time was scaled in days.
Sensitivity analyses. Five sensitivity analyses were conducted to validate the
findings from the original sample. The first sensitivity analysis selected a new
comparison cohort using exactly the same method as described above. The first
validation comparison cohort was 100% unique from the original comparison cohort.
A second sensitivity analyses used the original sample but selected only those in
VHA HBPC that were in the program for 6 or more months. This timeframe was
selected because it is plausible that reducing service use is not possible immediately
after an episode of disease or illness exacerbation, and because, this timeframe has
been examined in other studies (e.g., Chang et al., 2009). A third sensitivity analysis
selected another comparison cohort using all the same covariates used to generate the
propensity scores in the original sample except the variable ‘number of past
hospitalizations’ was replaced in the logistic regression model with the variable ‘number
of days since past hospitalization to initial treatment date’.
The fourth sensitivity analysis selected the comparison cohort based on the
implications from the previous analyses conducted in this study. This included adding
time to death and additional comorbidities to the matching algorithm and selecting the
cohorts only after an occurrence of an inpatient hospitalization. Time to death was
created in quartiles and added to the matching model. Also added to the model was the
presence of the following comorbidities (based on ICD-9-CM primary diagnosis codes):
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dementia, hip fracture or replacement, ulcer, pneumonia, respiratory failure, bone
marrow failure, sepsis, and debility unspecified. These were selected based on recent
research suggesting that claims data can be used to determine diminished functional
status (Chrischilles et al., 2014). The comorbidities selected were based on those that
were not already in the matching algorithm and those that were coded using ICD-9-CM
codes. Due to the selection of the cohort to only those with a hospitalization, the initial
treatment date represents the date of the baseline (FY 2009 or 2010) inpatient
hospitalization.
Finally, the fifth sensitivity analyses used the same cohort as the fourth but only
included those VHA HBPC enrollees that utilized VHA HBPC for six months or more.
This was done for the same reasons as stated above, because it is plausible that
reducing service use is not possible immediately after an episode of disease or illness
exacerbation, and because, this timeframe has been examined in other studies (e.g.,
Chang et al., 2009). Therefore, the initial treatment date for the treatment cohort in this
analysis is 180 days after the baseline (FY 2009 or 2010) inpatient hospitalization.
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Chapter 3: Findings
Sample
The sample was selected by identifying utilization of outpatient services
beginning in FY 2009 through FY 2010. During this timeframe, a total of 91,079
patients were identified as using VHA HBPC services and a total of 6,307,081 patients
were identified as non-VHA HBPC users. Of the VHA HBPC users, a total of 25,190
had only one VHA HBPC utilization. These patients were not considered VHA HBPC
enrollees but instead were used as potential controls. The look-back period (FY 20072008) identified 24,633 VHA HBPC users and these cases were discarded in order to
select only new users of the program. The final cohort for generating propensity scores
was comprised of 41,256 new VHA HBPC enrollees and 6,308,140 potential controls
(this selection is illustrated in Figure 3).
To estimate the causal effects of participation in VHA HBPC using observational
data from VHA administrative records, propensity scores were generated for matching
to identify a comparison group with similar characteristics as those who participated in
VHA HBPC. A logistic regression was used and included age, sex, race, Elixhauser
morbidity groupings, number of comorbidities, select ICD-9-CM procedures (i.e.,
palliative care and bereavement), and service eligibility to predict VHA HBPC enrollment.
Propensity scores were generated for 6,349,396 patients and represented the
predicted probability of participating in VHA HBPC. The average propensity score was
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Figure 3. Sample Selection

0.01 (SD = 0.02) with a range from < 0.01 to 0.96 prior to matching. After these
propensity scores were generated via logistic regression, the population was randomly
sequenced and matched one control to one treatment, without replacement, using
nearest neighbor matching and a caliper distance of 0.20 of the standard deviation of
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the logit of the propensity score to derive 41,244 matched pairs. Applying the caliper
method can result in unmatched treated cases if the propensity score of the control
cases was not within the distance specified of the treated case (Austin, 2014). In this
analysis, 12 treated cases were not matched and not included in the analyses of
outcomes. The post-match average propensity score was 0.04 (SD = 0.08) with a
range of < 0.01 to 0.90.
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Threshold

Figure 4. Standardized Differences Between Treatment and Control Groups

Given that the objective of this model was to balance observed covariates by
reducing residual variance rather than to predict exposure to VHA HBPC, the balance of
residual variance among covariates was examined in place of the usual examination of
model fit. In Figure 4, it is shown that the standardized differences (i.e., standardized
mean differences in units of the pooled standard deviation to compare balance in
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observed variables) before propensity score matching varied greatly compared to the
standardized differences after propensity score matching. Austin (2009a) recognized
that there is no consensus on the acceptable level of balance between groups that is
meaningful, but note that others have suggested standardized differences of 0.1
(represented by the dashed line in Figure 4) or below, which was achieved.
Moreover, Figures 5 and 6 show the change in the distribution of the logit of the
propensity scores before and after matching. Prior to matching, the logit of the
propensity scores had non-parametric density estimates of the distribution among the
potential comparisons. This non-normal distribution of the propensity scores in the
potential comparison group indicated that this group was not comparable to the
treatment group prior to matching.
After matching based on a caliper of 0.20 of the standard deviation of the logit of
the propensity score, density estimates of the distribution of the propensity scores
between groups was normalized. From Figure 6, the display of the density of the logit
of the propensity scores after matching, it can be concluded that the treatment and
selected controls are comparable in terms of their likelihood to be treated by VHA HBPC
given the observed covariates. The distributions of the logit of the propensity scores of
both groups were nearly identical.
The overlap assumption was met, also illustrated in Figure 6. That is, there were
controls throughout the entire range of the treatment group and vice versa. This is
important because at every level of the treatment group, there needs to be a
comparison case, and likewise, at every level of the control group there needs to be a

50

Figure 5. Density Plot of Propensity Scores Prior to Match

Figure 6. Density Plot of Propensity Scores Post-Match
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treatment case in order to continue with inferential analyses. This is clearly depicted in
Figure 6.
Descriptive statistics of the sample characteristics before and after matching are
provided in Table 1. As noted above, all but one covariate had significant differences
between the treatment and control groups prior to the match. After matching, nearly all
covariates were not significantly different based on treatment status. The exceptions
were age (0 to 64 years), number of past hospitalizations (3 or more), neurological
disorders, cancer, and palliative care use. Furthermore, distance from each patient’s
residence (using zip code) to the nearest VA medical facility offering VHA HBPC was
examined. It was concluded that there was not a significant difference between
treatment groups in the distance between residence and VA medical facility with VHA
HBPC.
Although the c-statistic typically indicates model fit, and in this case was 0.84, the
presented diagnostic methods were appropriate and necessary to determine the
adequacy of the matched sample generated by propensity scores via the logistic
regression (Austin, 2009a; Vittinghoff et al., 2012; Westreich, Cole, Funk, Brookhart, &
Sturmer, 2011). Nevertheless, the results from the model are presented in Table 2.
These results will not be interpreted given the objective of the model. As described, the
model was used to generate the propensity scores of which the diagnostics proved the
selected sample was balanced and comparable with the only observed difference being
the exposure to treatment (VHA HBPC).
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Table 1. Sample Baseline (FY 2009 & 2010) Characteristics of VHA HBPC vs. Comparison, Before and After
Matching Based on Propensity to Participate in VHA HBPC
Variables

Male
Age (in years)
0-64
65-74
75-84
85-111
Race
Black
Other
White
Missing
Service Eligibility
Not Connected
Number of Past
Hospitalizations
1
2
3
Comorbidities
CHF
Cardiac Arrhythmia
Valvular Disease
Pulmonary Circulation
Disorders
Vascular Disorders
Hypertension,
Uncomplicated

Hypertension,
Complicated
Paralysis

Before Matching
VHA HBPC
Comparison
n=41,256 n=6,308,140
n (%)
40,553 (98.3)
6,284,114 (99.6)**

After Matching
VHA HBPC
Comparison
n=41,244
n=41,244
40,542 (98.3)40,517 (98.2)

9,973 (24.2)
6,656 (16.1)
12,856 (31.2)
11,746 (28.5)

3,527,829 (55.9)**
1,097,651 (17.4)**
1,056,689 (16.8)**
441,920 (7.0)**

9,973 (24.2)
6,656 (16.1)
12,853 (31.2)
11,737 (28.5)

9,716 (23.6)*
6,732 (16.3)
12,811 (31.1)
11,880 (28.8)

6,038 (14.6)
2,313 (5.6)
26,839 (65.1)
6,066 (14.7)

727,009 (11.5)**
304,472 (4.8)**
3,468,822 (55.0)**
18,078,337 (28.7)**

6,037 (14.6)
2,312 (5.6)
26,829 (65.1)
6,066 (14.7)

6,072 (14.7)
2,335 (5.7)
26,889 (65.2)
5,948 (14.4)

22,664 (54.9)

3,434,188 (54.4)*

22,660 (54.9)

22,692 (55.0)

4,715 (11.4)
1,822 (4.4)
1,649 (4.0)

219,093 (3.4)**
62,062 (1.0)**
41,962 (0.7)**

4,710 (11.4)
1,819 (4.4)
1,646 (4.0)

4,801 (11.6)
1,713 (4.1)
1,414 (3.4)**

4,740 (11.5)
4,521 (11.0)
750 (1.8)

118,776 (1.9)**
312,524 (5.0)**
58,557 (0.9)**

4,734 (11.5)
4,518 (11.0)
749 (1.8)

4,691 (11.4)
4,547 (11.0)
747 (1.8)

430 (1.0)
2,754 (6.7)

16,712 (0.3)**
171,478 (2.7)**

430 (1.0)
2,752 (6.7)

418 (1.0)
2,855 (6.9)

17,478 (42.4)

2,245,724 (35.6)**

17,474 (42.4)

17,340 (42.0)

716 (1.7)
823 (2.0)

74,570 (1.2)**
23,459 (0.4)**

716 (1.7)
820 (2.0)

655 (1.6)
854 (2.1)
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Table 1. Sample Baseline (FY 2009 & 2010) Characteristics of VHA HBPC vs. Comparison, Before and After
Matching Based on Propensity to Participate in VHA HBPC (Continued)
Before Matching
After Matching
Variables (Continued)
VHA HBPC
Comparison
VHA HBPC Comparison
n=41,256
n=6,308,140
n=41,244
n=41,244
Neurological Disorders
3320 (8.1)
Chronic Pulmonary
Disease
7658 (18.6)
Diabetes
14031 (34.0)
Hyperthyroidism
922 (2.2)
Chronic Kidney Disease 2737 (6.6)
Liver Disease
518 (1.3)
Lymphoma
963 (2.3)
Metastatic Cancer
239 (1.0)
Cancer
(without metastasis)
4648 (11.3)
Rheumatoid Arthritis
7054 (17.1)
Coagulopathy
317 (1.0)
Obesity
1139 (2.8)
Weight Loss
1278 (3.1)
Anemia
842 (2.0)
Alcohol/Drug Abuse
3739 (9.1)
Psychoses
2499 (6.1)
Depression
8464 (20.5)
2 or More Comorbidities
29,412 (71.3)
Bereavement
1,150 (2.8)
Palliative Care
3,750 (9.1)
Average Number of Comorbidities

2.25 (1.2)

n (%)
117,357 (1.9)**

3,314 (8.0)

3,505 (8.5)*

517,967 (8.2)**
1,195,242 (19.0)**
148,119 (2.4)
168,927 (2.7)**
49,724 (1.0)**
120,716 (1.9)**
14,246 (0.2)**

7,654 (18.6)
14,024 (34.0)
922 (2.2)
2,733 (6.6)
518 (1.3)
963 (2.3)
239 (1.0)

7,733 (18.8)
14,062 (34.1)
888 (2.2)
2,686 (6.5)
527 (1.3)
930 (2.3)
272 (1.0)

346,228 (5.5)**
1,171,772 (18.6)**
27,542 (0.4)**
234,935 (3.7)**
46,235 (1.0)**
55,783 (1.0)**
632,754 (10.0)**
155,066 (2.5)**
1,158,969 (18.4)**
2,834,200 (44.9)**
33,495 (0.5)**
27,488 (0.4)**
M
SD
1.46 (1.2)**

4,647 (11.3)
7,052 (17.1)
317 (0.8)
1,139 (2.8)
1,277 (3.1)
840 (2.0)
3,739 (9.1)
2,496 (6.1)
8,463 (20.5)
29,400 (71.3)
1,144 (2.8)
3,738 (9.1)

4,892 (11.9)*
6,979 (16.9)
323 (0.8)
1,091 (2.7)
1,281 (3.1)
837 (2.0)
3,791 (9.2)
2,556 (6.2)
8,518 (20.7)
29,482 (71.5)
1,110 (2.7)
3,494 (8.5)*

2.25 (1.2)

2.26 (1.3)

CHF Congestive Heart Failure
*p < .05; **p < .001; each ‘no’ group was compared to the ‘yes’ group.
Data Source: VHA DSS Outpatient and Inpatient Data Files, FY 2009-2010.
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Table 2. Selected Multivariate Predictors of VHA HBPC Enrollment for Propensity Score Matching
Odds Ratio 95% Confidence Interval
Male
Age (in years)
65-74
75-84
85-112
Race
Missing
Black
Other
Service Eligibility
Not Connected
Number of Past
Hospitalizations
1
2
3
Comorbidities
Congestive heart failure
Cardiac Arrhythmia
Valvular Disease
Pulmonary Circulation Disorders
Vascular Disorders
Hypertension, Uncomplicated
Hypertension, Complicated
Paralysis
Neurological Disorders
Chronic Pulmonary Disease
Diabetes
Hyperthyroidism
Chronic Kidney Disease
Liver Disease
Lymphoma
Metastatic Cancer
Cancer (without metastasis)

0.46

0.43-0.50

2.04
4.53
9.95

1.97-2.10
4.39-4.66
9.65-10.26

0.64
1.47
1.04

0.62-0.65
1.43-1.51
0.99-1.08

0.83

0.81-0.84

2.35
2.83
3.57

2.27-2.43
2.68-2.98
3.36-3.79

2.64
1.26
0.98
1.51
1.47
1.01
0.58
4.09
3.41
1.79
1.80
0.79
1.36
1.62
0.89
1.18
1.20

2.55-2.73
1.21-1.30
0.91-1.06
1.36-1.67
1.41-1.53
0.99-1.04
0.53-0.63
3.80-4.42
3.28-3.55
1.74-1.84
1.75-1.84
0.73-0.84
1.29-1.42
1.48-1.78
0.83-0.95
1.03-1.36
1.16-1.24
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Table 2. Selected Multivariate Predictors of VHA HBPC Enrollment for Propensity Score Matching (Continued)
Odds Ratio 95% Confidence Interval
Rheumatoid Arthritis
Coagulopathy
Obesity
Weight Loss
Anemia
Alcohol/Drug Abuse
Psychoses
Depression
2 or More Comorbidities
Bereavement
Palliative Care

1.01
1.06
1.05
2.11
1.30
1.05
2.31
1.58
1.36
2.99
8.76

0.98-1.04
0.94-1.19
0.99-1.12
1.99-2.24
1.21-1.40
1.01-1.09
2.21-2.42
1.54-1.63
1.31-1.40
2.80-3.19
8.42-9.12

Bold indicates statistical significance at p < .05.
Data Source: VHA DSS Outpatient and Inpatient Data Files, FY 2009-2010.
Next, the propensity-score matched sample was used to determine the effect of the VHA HBPC on the outcomes of
interest. In this study, there are several outcomes of interest and each are described below using the described
propensity-matched sample.
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Aim 1
The overall objective of Aim 1 was to examine if there were differences in
healthcare utilization between those in VHA HBPC and those in the comparison group.
Table 3 describes the utilization rates by group. Average differences between groups
were tested with McNemar’s test to determine differences between any utilization
(yes/no) of a service type and t-tests were used to determine differences between
groups in the average number of utilizations for each service type.

Table 3. Descriptive Statistics for VHA-Paid Healthcare Utilization Among Those
in VHA HBPC and the Propensity-Matched Comparison Group, FY 2009-2012
VHA HBPC Comparison
VHA HBPC Comparison
% (n)
X (SD)
Any Hospitalization
(VHA and non-VHA)
54.55 (22,807) 35.57 (14,769)**
5.58 (7.08)
5.29 (7.72)**
VHA Hospitalization
47.65 (19,654) 31.82 (13,125)**
1.47 (2.53)
0.90 (2.03)**
Non-VHA Hospitalization 66.09 (7,938)
33.91 (4,073)**
3.18 (6.23)
3.08 (7.00)**
Nursing Home
2.67 (1,101)
1.62 (668)**
Outpatient
205 (170)
143 (137)**
n =sample size; X = average; SD = standard deviation.
**p < .001.
Data Source: VHA DSS Outpatient and Inpatient Data Files, FY 2009-2012.
Beginning with any hospitalization (VHA and non-VHA), a higher proportion of
VHA HBPC participants (54.55% versus 35.57%) utilized acute hospital care (p < .001).
The average number of hospital utilizations were similar between groups (VHA HBPC:
5.58, comparison: 5.29), but this small difference was statistically significant (p < .001).
Turning to inpatient VHA hospitalizations, there was a lower proportion of patients in the
comparison group (31.82%) who had an inpatient VHA hospitalization compared to
those in VHA HBPC (47.65%; p < .001). Additionally, the average number of inpatient
VHA admissions was higher among those in VHA HBPC (X = 1.47, SD = 2.53)
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compared to the comparison group (X = 0.90, SD = 2.03). This difference was
statistically significant, p < .001. For non-VHA hospitalizations, the proportion of VHA
HBPC participants who had an inpatient utilization was almost twice that of the
comparison group (66.09% versus 33.91%). Similarly, the average number of inpatient
utilizations was higher among VHA HBPC (3.18 versus 3.08, p < .001).
The relative risk of hospitalization was higher among those in VHA HBPC for any
hospitalization, VHA hospitalization, and non-VHA hospitalization (Table 4).
Table 4. Relative Risk of Hospitalization Among Those in VHA HBPC and the
Propensity-Matched Comparison Group Including Subgroup Stratification,
FY 2009-2012
RR
95% CI
Any Hospitalization (VHA and non-VA)
1.53 1.51 – 1.56
VHA Hospitalization
1.50 1.47 – 1.52
Age 85 & Older
1.47 1.42 – 1.52
Two or More Comorbidities
1.40 1.37 – 1.42
Recipients of Palliative Care
0.84 0.81 – 0.87
Non-VHA Provided Inpatient Care
1.94 1.87 – 2.00
Age 85 & Older
1.65 1.53 – 1.78
Two or More Comorbidities
1.82 1.75 – 1.89
Recipients of Palliative Care
0.94 0.87 – 1.03
RR = Relative Risk; CI = 95% Confidence Interval.
Bold indicates statistical significance at p < .05.
Data Source: VHA DSS Inpatient Data Files and Purchased Care Files, FY 2009-2012.
Post-hoc subgroup analyses were conducted to determine whether the effect of
VHA HBPC on hospitalization risks differs in certain subgroups (Table 4). These
analyses revealed that, relative to the comparison group, the risk of hospitalization for
those in VHA HBPC was significantly higher in nearly every subgroup for VHA and nonVHA hospitalizations. However, among those who received palliative care, those in
VHA HBPC had a significantly lower risk of an inpatient VHA admission relative to the
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comparison group (RR = 0.84, CI = 0.81 – 0.87). There was a non-significant difference
among recipients of palliative care for relative risk of non-VHA hospitalization.
Utilization of nursing home care was also examined. The findings, represented
in Table 3, indicate that a higher proportion of those in VHA HBPC (2.67%) utilized a
nursing home compared to the comparison group (1.62%; p < .001). Furthermore, the
relative risk of a nursing home admission was significantly higher among those in VHA
HBPC (RR = 1.65, CI 1.50 – 1.81). Post-hoc sensitivity analyses revealed that, among
the subgroups analyzed in this study, those with two or more comorbidities and those
age 85 and older in VHA HBPC had a higher risk of nursing home utilization relative to
the comparison group. There was not a significant difference in the relative risk of
nursing home utilization among who were recipients of palliative care.

Table 5. Relative Risk of Nursing Home Utilization Among Those in VHA HBPC
and the Propensity-Matched Comparison Group Including Subgroup Stratification,
FY 2009-2012
RR
95% CI
Nursing Home Utilization
1.65 1.50 – 1.81
Age 85 & Older
1.27 1.09 – 1.46
Two or More Comorbidities
1.73 1.54 – 1.94
Recipients of Palliative Care
1.08 0.76 – 1.54
RR = Relative Risk; CI = 95% Confidence Interval.
Bold indicates statistical significance at p < .05.
Data Source: VHA DSS Outpatient Data Files, FY 2009-2012.
Not surprisingly, a t-test revealed that those in VHA HBPC had a significantly
higher average number outpatient utilizations than those in the comparison group (203
vs. 143, respectively; F = 1.44, p < .001). Given that VHA HBPC is an outpatient
program, higher outpatient utilizations was expected. Risk analyses were not conducted
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for outpatient services since the use of outpatient services is expected among all
patients and represents a much wider array of care.
Due to a high number of expected deaths in this sample, a final post-hoc analysis
was conducted to provide further description of end-of-life care among those in VHA
HBPC (Figure 7). The overall rate of VHA hospitalization within 30 days of death was
15.93% for those in VHA HBPC versus 14.93% for those in the comparison. The rate of
VHA hospitalization within 60 days of death was 21.78% for those in VHA HBPC versus
18.81% for those in the comparison group, and finally, the rate of VHA hospitalization
within 90 days of death was 25.04% for those in VHA HBPC versus 21.52% for those in
the comparison group.
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Figure 7. Rate of VHA Hospitalization at 30, 60, and 90 Days Prior to Death by
VHA HBPC Status
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Results revealed that at 30, 60, and 90 days prior to death, VHA HBPC participants
were at significantly higher risk of a VHA acute hospitalization relative to the control
group overall and by subgroup analyses except for recipients of palliative care (Table 6).
Among those who received palliative care, VHA HBPC recipients had a lower risk of
hospitalization across all intervals prior to death relative to the comparison group.

Table 6. Relative Risk of Hospitalization Before Death Among Those in VHA HBPC
and the Propensity-Matched Comparison Group Including Subgroup Stratification,
FY 2009-2012
RR (95% CI)
Intervals Prior to Death
30 Days
60 Days
90 Days
Hospitalization (VHA)
1.11 (1.06 – 1.16) 1.16 (1.11 – 1.20) 1.16 (1.12 – 1.21)
Age 85 & Older
1.16 (1.08 – 1.26) 1.22 (1.14 – 1.30) 1.22 (1.15 – 1.29)
Two or More Comorbidities 1.08 (1.03 – 1.14) 1.12 (1.07 – 1.17) 1.11 (1.07 – 1.16)
Recipients of Palliative Care 0.69 (0.63 – 0.76) 0.73 (0.68 – 0.79) 0.75 (0.70 – 0.80)
RR = Relative Risk; CI = 95% Confidence Interval.
Bold indicates statistical significance at p < .05.
Data Source: VHA DSS Inpatient Data Files and Vital Status Files, FY 2009-2012.
Overall, the findings for Aim 1 did not support the hypothesis that VHA HBPC
would decrease risk of acute and nursing home care. Stratification analyses revealed
that these relationships did not vary by subgroup except among those who received
palliative care. There was generally no difference between groups among recipients of
palliative care in the risk of hospitalization or nursing home care except during the time
immediately prior to death for acute VHA hospitalization, which was the only findings
that supported the hypothesis.
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Aim 2
The objective of Aim 2 was to examine total average expenditures of healthcare
paid by the VA for those in VHA HBPC relative to a comparison group over the duration
of the study period. GLM was utilized to account for the nature of cost data and was
weighted by time in the study. The average time in the study was 1,104 (SD = 208)
days for those in VHA HBPC and 1,351 (SD = 248) for those in the comparison group (p
< .001). The SAS procedure GENMOD was utilized with the specifications of a gamma
distribution and a log link.
Overall, findings revealed that recipients of VHA HBPC had a significantly higher
average cost of care over the duration of the study period ($80,477 versus $42,325, p
< .001). As displayed in Table 7, when examining specific types of services, all service
costs were significantly higher among those in VHA HBPC relative to the comparison
group.
The mean cost of VHA HBPC over the duration of the study period was $17,667
per patient. When this cost was subtracted from the mean cost of outpatient care, VHA
HBPC recipients had a mean cost of $30,396 for outpatient care over the duration of the
study which was still a significantly higher average cost among VHA HBPC relative to
the comparison group (p < .001).
Table 7 displays the overall and post-hoc analyses by subgroups (i.e., the oldest
old, those with two or more comorbidities, and those who received palliative care) which
found that costs for VHA-provided services were significantly higher for VHA HBPC
recipients for all service types examined among all subgroups over the duration of the
study, with the exception for VHA hospital care among recipients of palliative care.
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Table 7. Average VA Expenditures Over the Duration of the Study Among Those
in VHA HBPC and the Propensity-Matched Comparison Group, FY 2009-2012
VHA HBPC ($)
Comparison ($)
Total Cost of VHA-Provided Services
80,477
42,325**
Hospital
32,387
17,788**
Outpatient Total
48,063
24,533**
VHA HBPC
17,667
-Non-VHA Provided Inpatient Care
5,329
2,508**
Grand Total
85,808
44,833**
Age 85 & Older
Total Cost of VHA-Provided Services
61,231
31,399**
Hospital
21,922
14,394**
Outpatient Total
39,298
17,002**
VHA HBPC
20,332
-Non-VHA Provided Inpatient Care
4,049
2,566**
Grand Total
65,280
33,966**
Two or More Comorbidities
Total Cost of VHA-Provided Services
84,837
47,299**
Hospital
34,847
19,921**
Outpatient Total
49,959
27,377**
VHA HBPC
18,017
-Non-VHA Provided Inpatient Care
5,362
2,575**
Grand Total
90,202
49,875**
Recipients of Palliative Care
Total Cost of VHA-Provided Services
89,908
78,009**
Hospital
34,165
44,642**
Outpatient Total
55,710
33,345**
VHA HBPC
27,171
-Non-VHA Provided Inpatient Care
5,071
5,797
Grand Total
94,983
83,807**
*p < .05; ** p < .001
Bold indicates the treatment group having significantly lower costs.
Data Source: VHA DSS Inpatient and Outpatient Data Files and Purchased Care Files, FY
2009-2012.
Among VHA HBPC palliative care recipients, costs were $34,165 compared to $44,642
for the comparison group recipients of palliative care (p < .001). There was a nonsignificant difference in cost between groups for hospital care over the duration of the
study among those ages 85 and older (p = .07 for VHA and p = .29 for non-VHA).
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The average cost of nursing home care over the duration of the study was $976
for those in VHA HBPC and $1,134 for those in the comparison. These numbers are
skewed due to the low utilization rate of nursing home services (VHA HBPC: 2.67%,
comparison group: 1.62%) which is likely why the models for nursing home care did not
converge, and thus, significance is not reported.
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Figure 8. Average Nursing Home Cost Over the Duration of the Study for Those
with Greater Than $0 Costs
Data Source: VHA DSS Outpatient Data Files, FY 2009-2012.
When restricting the sample to only those who utilized nursing home care, the
average was $34,201 for those in VHA HBPC and $42,492 for the comparison group
over the duration of the study. Figure 8 illustrates the difference in average costs
between groups for only those with greater than zero costs. In general, and among
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those ages 85 and older, VHA HBPC seems to reduce the cost of nursing home care.
However, for those with two or more comorbidities and for recipients of palliative care,
average nursing home costs are higher among those in VHA HBPC. Significance levels
are not reported since models did not converge.
The hypothesis that VHA HBPC would be associated with an overall lower cost
of healthcare for VHA-paid services was not supported. Costs were generally higher
among those in VHA HBPC with the exception of the costs associated with VHA acute
hospitalizations among palliative care recipients.
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Aim 3
The objective of Aim 3 was to examine if there was a survival differential
associated with participation in VHA HBPC. A total of 25,884 (62.79%) patients in VHA
HBPC died during the study period compared to 17,834 (43.28%) patients in the
comparison group (p < .001). As Table 8 shows, findings reveal that the risk of death
was significantly higher among those in VHA HBPC (RR = 1.45, 1.43 – 1.47) relative to
the comparison group.

Table 8. Relative Risk of and Time to Death Among Those in VHA HBPC and the
Propensity-Matched Comparison Group, FY 2009-2012
RR /Hazard Ratio 95% CI
Died
Relative Risk
1.45 1.43 – 1.47
Survival Time
1.89 1.86 – 1.93
RR = Relative Risk; CI = 95% Confidence Interval.
Bold indicates statistical significance at p < .05.
Data Source: VHA DSS Outpatient Data Files and Vital Status Files, FY 2009-2012.
A Cox proportional hazards model with a robust variance estimator to account for
clustering was fit to the matched sample to determine if there was a significant
difference between groups in time to death. The model contained exposure to VHA
HBPC and quintiles of the logit of the propensity score as predictors since covariate
adjustment was already applied to the sample. The average time to death was 979
days (SD = 534), or just over two and a half years from initial treatment date for those in
VHA HBPC, and 1,226 days (SD = 414), or three and a quarter years from initial
treatment date for those in the comparison group. This difference was statistically
significant at p < .001. The hazard ratio for mortality among those who participated in
VHA HBPC was 1.89 (CI 1.86 – 1.93). This indicates that those in VHA HBPC died
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sooner, on average, than those who died in the comparison group. This relationship is
graphically displayed via Kaplan-Meier survival curves in Figure 9, below. The solid
blue line represents the survival estimates over time for the control group, which is
significantly more favorable in comparison the survival estimates for those in VHA
HBPC, represented by the dashed red line indicating sooner time to death.

Time to Death
VHA HBPC
Controls

Figure 9. Survival Time From Initial Treatment Date Among Those in VHA HBPC
and the Propensity-Matched Comparison Group, FY 2009-2012
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Also revealed by the Cox proportional hazards model was the significance of the
propensity score quintiles in predicting time to death. All quintiles were significant
predictors, and the higher the quintiles, the sooner death occurred (quintile 1: reference;
quintile 2: HR = 1.84, 1.78-1.92; quintile 3: HR = 2.39, 2.31-2.48; quintile 4: HR = 3.08,
2.97-3.19; quintile 5: HR = 4.64, 4.48-4.80). This suggests that there is an association
between time until death and the likelihood of VHA HBPC treatment.
Post-hoc analyses were conducted to determine if the risk of death varied by
subgroups (Table 9). Results indicate that the rate of death was higher among those in
the VHA HBPC subgroups of adults ages 85 and older (80.50% vs. 66.13%, p < .001)
and those with two or more comorbidities (62.34% vs. 43.03%, p < .001) compared to
the same subgroups in the comparison group. Among recipients of palliative care, the
comparison group had a higher rate of death (89.77%) compared to VHA HBPC
(86.54%, p < .001). Accordingly, the relative risk was higher among VHA HBPC
recipients who were ages 85 and older (RR = 1.45, CI 1.43 – 1.47) and those with two
or more comorbidities (RR = 1.22, CI 1.20 – 1.24). However, among those who
received palliative care, VHA HBPC recipients had a slightly lower relative risk of death
(RR = 0.96, CI 0.95 – 0.98).
Table 9. Post-Hoc Sensitivity Analyses to Examine Relative Risk of Mortality
Among Those in VHA HBPC and the Propensity-Matched Comparison Group,
FY 2009-2012
RR
95% CI
Age 85 & Older
1.45
1.43 – 1.47
Two or More Comorbidities
1.22
1.20 – 1.24
Recipients of Palliative Care
0.96
0.95 – 0.98
RR = Relative Risk; CI = 95% Confidence Interval.
Bold indicates statistical significance at p < .05.
Data Source: VHA DSS Outpatient Data Files and Vital Status Files, FY 2009-2012.
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In sum, the results indicated that the hypothesis of a survival differential between
VHA HBPC and the comparison group was supported by the evidence. Recipients of
VHA HBPC, in general, were at a higher relative risk of death and on average died
significantly sooner relative to the comparison group. The only exception was among
recipients of palliative care, those in VHA HBPC survived slightly longer than those in
the comparison group. Considering the results of the three aims varied from
expectations, several sensitivity analyses were conducted.
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Sensitivity Analyses
Multiple iterations of sensitivity analyses were conducted to either validate the
reported findings or to better describe the effect of VHA HBPC taking into account the
implications of the previously reported findings. The first sensitivity analysis selected a
new comparison cohort 100% unique from the original. These results were nearly the
same as the first and are not discussed here.
The second sensitivity analysis used the original cohorts but redefined the
treatment group as those in VHA HBPC for six months or more. The third sensitivity
analysis modified the original matching algorithm by replacing ‘the number of past
hospitalizations’ with the ‘time since last hospitalization’. In this cohort, there were
40,368 matched pairs. Approximately 9% (3,630) of controls are the same cases
between the first and third validation cohorts, but none are the same as the original
control cohort (i.e., the third validation cohort was 100% unique from the original sample
of controls).
From the original comparison cohort to the fourth comparison cohort there was
71% overlap in the control group. This cohort was selected by refining the matching
algorithm further to include time to death and additional comorbidities and selected the
sample based on the occurrence of an inpatient hospitalization. This group was
comprised of 29,471 matched pairs. Finally, the fifth round of sensitivity analyses used
the fourth cohort but restricted the VHA HBPC cohort to only those that utilized the
program for six months or more.
The results for the relative risk of hospitalization and nursing home use are
presented in Table 10. From the original analysis to the second sensitivity analysis, the
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results were very similar to the original. The only difference in significance was among
recipients of palliative care in VHA HBPC who had a significantly lower risk of non-VHA
hospitalization compared to recipients of palliative care in the comparison group from
the second sensitivity cohort. With one exception, all other analyses of risk for hospital
or nursing home use remained significant, and in cases where there was an increased
risk for hospitalization, the degree of increased risk lessen from the degree of risk in the
original cohort to the second sensitivity cohort. This indicates that the risk of the use of
these services remains higher than the comparison group but the risk is tempered over
time since the second sensitivity cohort only looked at the use of services among those
in VHA HBPC for six or more months.
Data for non-VHA hospitalizations were not available for the third sensitivity
analyses. Nevertheless, the results for the third sensitivity analyses suggest that the
number of days since prior hospitalization did not change the results of the risk of
service use, overall. The risk for VHA hospitalization remained at levels indicated in the
original cohort and the risk for nursing home services that were significant in the
original cohort remained significant in the third sensitivity analyses, but to a lesser
degree than the original cohort.
The fourth and fifth sensitivity analyses suggest that refining the matching
algorithm by adding time to death and additional comorbidities, in addition to only
including those with a baseline inpatient VHA hospitalization, impacts the effect of VHA
HBPC on service use. While the risk of VHA hospitalization remained higher for the
VHA HBPC enrollees relative to the comparison group in general in the fourth sensitivity
cohort, the risk of nursing home utilization was significantly less for VHA HBPC
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enrollees overall and among VHA HBPC enrollees in the age strata of 85 years and
older. Among those with two or more comorbidities, the relative risk changed from
significantly higher among VHA HBPC enrollees in the original cohort to significantly
lower in the fourth cohort. After restricting the fourth cohort to only those in VHA HBPC
for six or more months (i.e., the fifth cohort), the lower risk of nursing home use among
VHA HBPC enrollees from the fourth cohort was even lower in the fifth cohort.
Additionally, the fifth cohort was the only cohort that showed significantly lower risks for
VHA and non-VHA hospitalization relative to the comparison group. This remained true
for all strata examined. The results indicate that time to death, selection based on
hospitalization, and additional comorbidities are necessary when examining the risk for
service use among VHA HBPC participants. Additionally, these results indicate that the
effect of VHA HBPC cannot be determined immediately, and six months after the initial
treatment, different results should be expected.
Table 11 describes the results of the sensitivity analyses for expenditures.
Expenditures for the third sensitivity cohort were not examined since the use of services
was very similar to the original cohort. The results from Table 11 show that VHA HBPC
enrollees incur significantly higher costs overall compared to a matched comparison
group. The only evidence of lower expenditures is in the fifth sensitivity cohort for VHA
hospitalization, but this savings was not enough to produce lower expenditures overall
among VHA HBPC enrollees relative to the matched comparison group.
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Table 10. Relative Risk of Hospitalization Comparing the Original Cohort to Sensitivity Cohorts, Including
Subgroup Stratification, FY 2009-2012
Original Cohort

Second Cohort
(Original,
6 mo.)
RR 95% CI
1.36 1.34-1.39
1.35 1.32-1.38
1.35 1.30-1.41
1.25 1.22-1.37
0.75 0.71-0.79
1.52 1.47-1.58
1.39 1.28-1.50
1.43 1.37-1.50
0.74 0.67-0.82
1.59 1.44-1.76
1.23 1.06-1.44
1.64 1.45-1.86
0.97 0.66-1.43

Third Cohort
(+Days Last Hospital)

RR
95% CI
RR
95% CI
Any Hospitalization (VHA & non-VA)
1.53
1.51 – 1.56
VHA Hospitalization
1.50
1.47 – 1.52
1.47
1.45 – 1.50
Age 85 & Older
1.47
1.42 – 1.52
1.47
1.42 – 1.52
Two or More Comorbidities
1.40
1.37 – 1.42
1.37
1.34 – 1.40
Recipients of Palliative Care
0.84
0.81 – 0.87
0.81
0.78 – 0.84
Non-VHA Provided Inpatient Care*
1.94
1.87 – 2.00
Age 85 & Older
1.65
1.53 – 1.78
Two or More Comorbidities
1.82
1.75 – 1.89
Recipients of Palliative Care
0.94
0.87 – 1.03
Nursing Home Utilization
1.65
1.50 – 1.81
1.42
1.30 – 1.56
Age 85 & Older
1.27
1.09 – 1.46
0.99
0.87 – 1.14
Two or More Comorbidities
1.73
1.54 – 1.94
1.48
1.32 – 1.66
Recipients of Palliative Care
1.08
0.76 – 1.54
0.92
0.65 – 1.29
*This data were not available for all cohorts.
RR = Relative Risk; CI = 95% Confidence Interval.
Bold indicates statistical significance at p < .05.
Data Source: VHA DSS Outpatient and Inpatient Data Files, and Purchased Care Files, FY 2009-2012.

Fourth Cohort
(+Death time &
Comorbidities)
RR
95% CI
1.25
1.23 – 1.27
1.41
1.38 – 1.45
1.42
1.35 – 1.50
1.39
1.35 – 1.42
1.06
0.99 – 1.12
1.02
1.00 – 1.04
1.02
0.98 – 1.07
1.03
1.01 – 1.05
0.99
0.92 – 1.06
0.88
0.80 – 0.97
0.62
0.53 – 0.73
0.90
0.81 – 1.01
1.15
0.79 – 1.69

Fifth Cohort
(+Death time
Comorb., 6 mo.)
RR 95% CI
0.91 0.90-0.92
0.89 0.88-0.90
0.82 0.80-0.85
0.89 0.88-0.90
0.74 0.71-0.77
0.88 0.86-0.90
0.88 0.84-0.92
0.89 0.87-0.91
0.88 0.82-0.95
0.74 0.67-0.81
0.54 0.45-0.64
0.76 0.68-0.86
0.77 0.50-1.17

Table 11. Average VA Expenditures Among Those in Original Cohort Compared to Sensitivity Cohorts
Original Sample

Second Validation
(Original: 6-mo.)

Fourth Validation
(+Death time &
Comorbidities)

HBPC Comparison
HBPC Comparison
HBPC Comparison
Total Cost of VHA-Provided Service
80,477
42,325**
80,000
42,325**
107,950 69,125**
Hospital
32,387
17,788**
23,348
18,111**
51,010 32,454**
Outpatient Total
48,063
24,533**
34,563
24,700**
56,935 36,659**
Non-VHA Provided Inpatient Care
5,329
2,508**
4,354
2,617**
13,008 13,198
Grand Total
85,808
44,833**
87,294
46,121**
123,748 84,315**
** p < .001
Bold indicates the treatment group having significantly lower costs.
Data Source: VHA DSS Outpatient and Inpatient Data Files, and Purchased Care Files, FY 2009-2012.

Fifth Validation
(+Death time &
Comorbidities, 6 mo.)
HBPC Comparison
89,761
85,371**
46,107
48,693**
43,680
36,659**
11,071
13,198
103,358 100,519**
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Chapter 4: Discussion
Summary
The VHA characterizes quality care as: the right type of care; care that results in
the best outcome; patient-centered care; and care free from harm and hazards (U.S.
Department of Veterans Affairs, 2014). As a central component to providing quality of
care, the VHA strives to focus on what matters to the patient. Thus, VHA HBPC
remains a critical alternative to institutional care or care dependent upon caregivers by
bringing health professionals to the patient. By enabling patients to remain in their
homes and receive care that they might otherwise forgo, the VHA is assisting patients in
achieving their health-related goals.
This study found that without accounting for critical factors (i.e., time to death,
baseline hospitalization, and an additional array of comorbidities), VHA HBPC appeared
to be associated with higher risk for hospital and nursing home use, higher expenditures,
and higher risk of death. However, the findings that indicated that VHA HBPC is
associated with likelihood of death should be accounted for in analyses that assess the
impact of VHA HBPC. This is a major contribution of this study. This is supported by
other research suggesting that homebound individuals have a higher risk of death within
two years compared to non-homebound individuals and suggest that homebound status
should be considered an indicator of frailty (Herr, Latouche, & Ankri, 2013). This
difference in the original analyses and several of the early sensitivity analyses could
explain why the program was not producing the expected results.
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After accounting for time to death, baseline hospitalization, and additional
comorbidities, the results were closer to the hypothesized outcomes. Specifically, VHA
HBPC can affect the relative risk of hospitalization after a certain period of longevity in
the program. In this study, six months was used as the point in time in which the
relative risk was assessed. After six months (and after the inclusion of additional
comorbidities, time to death, and hospitalization as inclusion criteria), VHA HBPC
participants had a lower risk of hospitalization and nursing home use relative to a
comparison group, albeit higher total expenditures.
Prior to the refinement of the matching algorithm and inclusion criteria, VHA
HBPC recipients of palliative care had lower acute care utilization overall and
immediately prior to death compared to a similar group of patients not receiving VHA
HBPC. Additionally, VHA HBPC recipients of palliative care survived longer than the
comparison group. These findings are highlighted because VHA HBPC participants
have a high rate of death. In this study, more than 62% of VHA HBPC participants in
the original cohort died over a three year period. Even after the refinement of the
matching algorithm, recipients of palliative care generally had a lower rate of VHA
hospitalization, overall.
The question should be raised as to whether VHA HBPC is an end-of-life
program. The program seems effective in keeping participants receiving palliative care
out of the hospital, especially during the 30 to 60 days prior to death in all cohorts, but
further research is needed to better understand this association. Moreover, the findings
here are underscored by a previous study (Hughes et al., 1992) that similarly found that
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VHA HBPC was effective in keeping patients home for longer in the time prior to death
compared to a comparison group.

Relation to Other Evidence
The findings here are supported by those in the Hughes et al. (2000) study which
found that those in VHA HBPC had higher costs than a randomized control group. A
difference between these results and the Hughes study is in the service utilization
associated with costs. In the Hughes study, only outpatient services were significantly
reduced and home-based care and nursing home costs were significantly higher. The
results from this study suggest that outpatient services were not reduced, and generally,
VHA HBPC participants had higher service use and cost across the board. The
differences in the details of costs are not surprising given the general inflation of
healthcare costs over time. Nevertheless, the “bottom line finding” regarding total costs
was the same between studies: VHA HBPC did not reduce overall cost of care when
compared to a similar control group.
Previous studies finding reduced cost associated with VHA HBPC should not be
overlooked. Studies of VHA HBPC that found cost savings (Cummings et al., 1990;
Hughes et al., 1992) were from the 1980’s and before a time when aggregated cost
records were kept in administrative databases that would allowed for large scale
analyses, like that conducted here. A more recent cost analysis was conducted for
Medicare’s Independence at Home program and suggested that participants had
significantly lower costs, especially among the most frail (De Jonge et al., 2014).
However, these two programs generally operate in two different systems of care, and
although service utilization overlap occurs, direct comparisons between programs are
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difficult. A closer look at the most frail VHA HBPC recipients is warranted, but
measures of frailty are difficult using administrative data.
Based on the original analysis and early sensitivity analyses, this study did not
support others that found a general reduction in hospital utilization associated with VHA
HBPC or similar home-based primary care programs (Chang et al., 2009; Edes et al.,
2014; Hughes et al., 1992; Wajnberg et al., 2010). However, these previous studies
used pre-post enrollment designs. For example, reduced utilization is what Edes et al.
(2006) and Edes et al. (2014) found in their smaller study of the Missouri VHA HBPC
program and a more recent, larger study of VHA and Medicare. Specifically, VHA
HBPC was considered cost effective from the perspective of the expected cost of VHA
HBPC participants (based on pre-enrollment service use) compared to the observed
cost (based on post-enrollment service use).
The current study did not determine if there were service use reductions and cost
reductions after admission to VHA HBPC compared to prior to VHA HBPC, as the
aforementioned studies concluded. The service use and cost trajectory could have
been changed due to participating in the program, as previous evidence suggested, but
this type of comparison was not the goal of the present study. This study adds to the
evidence base that, when compared to a similar group of patients receiving usual care,
VHA HBPC does not reduce the relative risk of hospitalization initially, and VHA HBPC
should not be characterized as lowering expenditures.
In addition to the difference of a pre/post design versus comparative analyses,
other differences in study designs exist that could explain the differences and
similarities in findings between past research findings and those described here. A
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handful of studies examined disease specific populations rather than the entire program
population, as was done in this study. Edwards et al. (2014) examined enrollees with
diabetes and found decreased hospital use. Hughes et al. (2000) investigated those
with two or more functional impairments, congestive heart disease, or chronic
obstructive heart disease and found lower hospital readmission rates at six months.
Edes et al. (2006) examined end stage heart and lung disease patients and found lower
use and cost. These findings are similar to those in the Medicare Independence at
Home Demonstration that found the program effective for the frailest group of
participants (De Jonge et al., 2014). Similar to the findings presented here, Chang et
al.’s (2009) study utilized a six-month post enrollment design, and like this study, found
lower hospital use.
The findings here that evidenced a lower relative risk of death among those
receiving VHA HBPC and palliative care are similar to the findings in a study examining
the effect of palliative care on patient-reported outcomes and end-of-life care among
patients with a new diagnosis of non-small-cell lung cancer (Temel et al., 2010). In
Temel et al.’s study, the mean survival time was 11.6 months for those receiving
palliative care compared to 8.9 months for those receiving usual care (p = 0.02). Other
positive findings have been associated with the receipt of palliative care among complex
patients. For example, among Medicaid patients with cancer, palliative case
management was associated with lower inpatient admissions, lower intensive care unit
admissions, longer average days on hospice, and lower rate of death in the hospital
compared to those in the comparison group (Wang, Piet, Kenworthy, & Dy, 2015). The
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overall favorable findings regarding VHA HBPC and palliative care warrant further
investigation.

Andersen’s Behavioral Model
Andersen’s behavior model was adapted for VHA HBPC was used to develop the
conceptual model for this study. Predisposing factors (i.e., age, race, and sex) were
generally balanced between the control and treatment groups. Proposed enabling
factors in this study included geographic location, the receipt of palliative care,
insurance status, and receipt of the VHA HBPC. It was determined through t-tests that
there was not a geographic difference between the treatment and control group in terms
of miles from individual’s residences and the VA medical center providing VHA HBPC.
Therefore, geographic location likely did not impact the effects of the program on
outcomes, overall. Also balanced was the proportion of those service eligible which
was the proxy for insurance status. Due to data limitations, examining the effect of
hospice was not enabled but it was determined that VHA HBPC recipients of palliative
care had better outcomes in terms of lower service utilization than did the control group
who received palliative care. This effect was generally true across cohorts, and without
more analyses, it is difficult to disentangle the effects of the program from the effects
from receiving palliative care.
Two factors from Andersen’s Health Behavior Model likely influenced the results
which were the receipt of VHA HBPC (an enabling factor) and need for care. While
diagnoses were used to account for comorbidity (as a proxy for need for care), the level
of disease severity (and therefore, the precise level of need) was indiscernible. After
accounting for confounding by controlling for time to death, two groups that were more
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similar in terms of likelihood for mortality-related processes (and possibly need for care)
were created. Therefore, need for care played a confounding role in the results in the
first set of analyses, but after creating a control group that likely reduced residual
variance, the enabling factor of receiving VHA HBPC had an effect by decreasing the
risk of service use relative to the comparison group. The strong influence of need was
also described by others who found it to have influential effects in a Veteran population
(Elhai et al., 2008).

Interpretation, Limitations, and Future Research
Given the higher average number of utilizations and higher relative risk of acute
hospitalization relative to the comparison group in cohorts that did not restrict to six
months of program enrollment, it is likely that there are one or more subgroups of VHA
HBPC recipients who could be considered “frequent fliers”. Past research has led to
suggestions that those who experience complicated transitions from one setting to
another after an acute hospitalization are more likely to be those who are more
vulnerable and suffer disproportionately during care handoffs (Coleman, 2007). If this is
the case for VHA HBPC recipients, further research is critical to enhance the quality of
care provided to these patients. Future analyses should focus on high utilizers and
transitional care for those in VHA HBPC.
The results of high resource utilization are not surprising. More care, in this case
provided by VHA HBPC, can often lead to even more care, which in turn leads to higher
costs. A possible explanation for these findings are that, given that VHA HBPC
recipients are in a program of care, their care could be monitored more closely than that
of the comparison group yielding a “surveillance bias”. This phenomenon is one
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suggesting that the more you look, the more you find. Since those in VHA HBPC are
being provided care regularly, they may have a higher likelihood of receiving additional
needed services. Another scenario, not necessarily an alternate explanation, but
perhaps additional possibility, is that VHA HBPC recipients are experiencing more
emergency department utilizations. The reason for this suggestion is based on the
nature of the administrative data used in this study. Emergency department utilizations
are categorized as outpatient services. Although the cost of emergency services are
accounted for by the data, the actual type of outpatient service utilized is limited by not
being able to determine emergency services and is an area for further investigation.
The findings from this study could be limited by an averaging effect. While
focusing on between-patient outcomes, the effects of intra-individual differences are
minimized with the assumption that all individuals follow a similar pattern. Withinperson differences likely exist in this population given the proportion of the individuals
who were near death. Specifically, terminal decline, or the decrements in individuals’
functional capacities that span the time from months to years before death, has intraindividual variation that is a within-person process (Gerstorf & Ram, 2013). However,
these differences become masked in between-person analyses, such as those
conducted in this study. However, some of the within-person variation is accounted for
in the later analyses that controlled for time to death since time to death can serve as a
proxy for unnamed mortality-related casual processes (Gerstorf & Ram, 2013).
Additionally, program variation is likely and should be examined in relation to
service use and cost (Olsan et al.). Program leaders have suggested that variation in
the duration and intensity of services exist across programs. Some programs operate
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on a shorter-term acute basis, where others implement the program as long-term and
continuous. Additionally, program leaders have suggested that future work should
examine differences in outcomes based on the programs that focus on primary care
versus those that implement an interdisciplinary care approach.
In terms of intensity, the average VHA HBPC caseloads are between 20 to 30
patients to each registered nurse (or licensed practical nurse), 80 to 105 per social
worker, 85 to 155 per rehabilitation therapist, and 95 to 125 per dietician. Given these
high caseloads, future research would be behooved to examine whether the size of the
caseloads effect outcomes. Perhaps more staffing results in better care and improved
outcomes such as preventing avoidable service use (e.g., hospitalizations) and lowering
expenditures. Increased staffing levels have been associated with positive outcomes in
other studies, for example, in acute care hospitals (Kane, Shamliyan, Mueller, Duval, &
Wilt, 2007), nursing homes (Konetzka, Stearns, & Park, 2008), and in assisted living
facilities (Stearns et al., 2007). In this study, an intent-to-treat design was utilized in that
service intensity (referred to as a proxy for staffing) was not a requirement in order to
determine the effects of the program on the outcomes.
Although this study refined the matching algorithm and inclusion criteria to an
extent, other areas for future research include further refinement to the matching
method and should consider other frailty indices, alternative matching techniques, and
further restriction of the matching caliper. It would be advantageous if measures related
functional limitations, cognition, and the availability of caregiver assistance were
available for matching in future studies.
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The inability to control for patient frailty is a limitation of this study. Other studies
examining the effect of VHA HBPC found that those with the highest frailty scores had
lower costs suggesting that this group has the greatest potential for savings (De Jonge
et al., 2014). Although further investigation into frailty indices may be warranted, others
have suggested that diagnoses using ICD-9-CM codes, as was done in this study,
compared to the use of measures of functionality, were better predictors of mortality
among a frail population (Levy et al., 2015).
Another limitation of this study is that propensity scores are generated from
observed covariates, therefore, if there are associations between unobserved factors
and probability of treatment, these are not accounted for and such residual differences
could exist. Additionally, there is inherent subjectivity in deciding which propensity
score method to use (e.g., matching, adjustment, inverse weighting). Since the
propensity score approach involved two models, if either model is incorrect, biased
estimates of the causal effect are possible (Vittinghoff et al., 2012).
Other limitations include the dichotomized nature of the service eligibility variable.
A more nuanced approach to examining service eligibility could provide a better
understanding of the effect of VHA HBPC compared to how different levels of service
eligibility effect service use. A notable limitation is the lack of Medicare data. A
complete picture of the effect of VHA HBPC would be provided by merging Medicare
files with VA files. However, this study was restricted to VA data. The presence of
advance directives was not accounted for which could affect service use. Finally,
measures of quality of care were not accounted for in this study due to the nature of the
data.
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Strengths of the study include the use of population-based, longitudinal VHA data,
and the study design which addressed statistical challenges including selection bias and
yielded relatively well-matched comparison cohorts to draw conclusions regarding the
effect of VHA HBPC. Ethical considerations limit the ability to conduct randomized
controlled trials to determine the effect of any healthcare delivery models. Thus, this
study used matched comparison groups to understand the effect of VHA HBPC on
service utilization, cost, and survival.

Policy Recommendations
Several policy recommendations can be made based on the findings from this
study. First, more research should be supported in order to better understand the
effectiveness of VHA HBPC. First, program variation is likely and understanding how
programs different and how such a differences effect outcomes would be advantageous
to the program’s longevity. Additionally, research support should be provided to gain a
better understanding into the effects of VHA HBPC recipients who receive palliative
care. The research from this study suggests that VHA HBPC recipients receiving
palliative care could possibly be an effective subgroup to target for optimal outcomes.
These findings are not surprising given past research suggesting that participating in
palliative care following hospitalization can have a beneficial effect on service use, cost,
and satisfaction with care (Brumley, Enguidanos, & Cherin, 2003; Gade et al., 2008).
Understanding how palliative care and VHA HBPC work in conjunction to produce
positive outcomes is warranted.
Another policy recommendation is to develop a method to identify an appropriate
group of VHA HBPC participants that would benefit from palliative care. Given the
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findings from this research and others, palliative care can have a multitude of beneficial
effects. It would be justified to provide clinical guidance in terms of identifying patients
in VHA HBPC who could benefit from such services. A checklist could be implemented
such as the ones developed by The Center to Advance Palliative Care’s Consensus
Panel which developed two checklists to screen patients for unmet palliative care needs
(Weissman & Meier, 2011). Palliative care services can be provided in conjunction with
restorative care. Therefore, this recommendation is not specific to end-of-life care.
To address end of life, it is recommended that training in end-of-life care be
provided for the clinicians and staff of VHA HBPC. Given the high rate of death of
program participants, it is likely that end-of-life issues arise frequently whether they be
related to clinical care or psychosocial issues. Therefore, specialized, continuous endof-life care trainings for all those involved with VHA HBPC patient-care should be
provided.
The final policy recommendation is to develop clinical guidelines and/or best
practices for which VHA HBPC programs can utilize. This patient population is
vulnerable and complex and providing care in one’s home likely presents situations that
clinic-setting professionals do not confront. Therefore, in order to optimize the
effectiveness of the program, guidelines should be provided to clinicians serving
patients in VHA HBPC. Additionally, these guidelines should be updated as research
on the program evolves.
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Conclusions
Past research found that, among a sample of VHA patients, interactions with the
health-care system and with providers were major concerns and presented significant
obstacles to self-care (Noel, Frueh, Larme, & Pugh, 2005). For those that have
significant difficulty with getting to the clinic to receive care, VHA HBPC provides an
option to alleviate access barriers such as transportation, mobility, and the general
difficulty in navigating the system by bringing services into the patient’s home. Some
have even gone as far as to suggest that advances in medicine and technology allow
complex care to be delivered to certain patients in their homes and is comparable to
being treated in the hospital (Boling et al., 2013). While this study did not address the
comparability of hospital care to home care, the results of this study – at least in terms
of those in the program for six or more months and palliative care recipients underscore the idea that successful home-based programs, such as VHA HBPC, should
be maintained to address the unmet needs of patients and Veterans who need care
provided in the home, albeit the need for further examination on program effectiveness.
Although this study did not find lower expenditures as a result of VHA HBPC
participation, reduced nursing home use and hospitalization can be expected after six
months of program participation. Though not captured in this study, patient and
caregiver satisfaction have been reported elsewhere (Beck, Arizmendi, Purnell, Fultz, &
Callahan, 2009; Cummings et al., 1990; Edes et al., 2014; Hughes et al., 2000) and as
others have suggested, favorable outcomes are not always correlated with high patient
satisfaction (Kennedy, Tevis, & Kent, 2014). Factors outside of desired outcomes seem
to influence patient satisfaction and this appears to be the case for those in VHA HBPC.
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Although VHA HBPC only serves a fraction of the VHA patient population,
recipients of VHA HBPC are a vulnerable population who have multiple chronic
conditions that are often characterized as costly and account for a disproportionate level
of resource utilization, as evidenced through this study. However, this does not mean
that the program is not effective in meeting the needs of these patients or doesn’t assist
in keeping patients independent for longer than otherwise expected, although the
findings here cannot speak to this effect. A modest impact on resource use with little to
no impact on expenditures has been reported in other programs that attempt to manage
patients with complex, chronic conditions in the community (Agency for Healthcare
Research and Quality, 2013a; Peikes, Chen, Schore, & Brown, 2009; Weinberger,
Oddone, & Henderson, 1996). Like these, this study should not undermine the value of
the program to the patient, but should be used to improve care by providing insight as to
where improvement and research efforts should focus.
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